| Year |
Citation |
Score |
| 2024 |
Ali H, Malik MZ, Abu-Farha M, Abubaker J, Cherian P, Nizam R, Jacob S, Bahbahani Y, Naim M, Ahmad S, Al-Sayegh M, Thanaraj TA, Ong ACM, Harris PC, Al-Mulla F. Global analysis of urinary extracellular vesicle small RNAs in autosomal dominant polycystic kidney disease. The Journal of Gene Medicine. 26: e3674. PMID 38404150 DOI: 10.1002/jgm.3674 |
0.321 |
|
| 2024 |
Sabov M, Denic A, Mullan AF, Luehrs AC, Kline TL, Erickson BJ, Potretzke TA, Thompson RH, Sharma V, Harris PC, Rule AD. Association of Kidney Cysts With Progressive CKD After Radical Nephrectomy. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 38280640 DOI: 10.1053/j.ajkd.2023.11.016 |
0.317 |
|
| 2024 |
Ali H, Alahmad B, Senum SR, Warsame S, Bahbahani Y, Abu-Farha M, Abubaker J, Alqaddoumi M, Al-Mulla F, Harris PC. PKD1 Truncating Mutations Accelerate eGFR Decline in Autosomal Dominant Polycystic Kidney Disease Patients. American Journal of Nephrology. PMID 38194940 DOI: 10.1159/000536165 |
0.464 |
|
| 2023 |
Yang H, Sieben CJ, Schauer RS, Harris PC. Genetic Spectrum of Polycystic Kidney and Liver Diseases and the Resulting Phenotypes. Advances in Kidney Disease and Health. 30: 397-406. PMID 38097330 DOI: 10.1053/j.akdh.2023.04.004 |
0.461 |
|
| 2023 |
Aklilu AM, Gulati A, Kolbert KJ, Yang H, Harris PC, Dahl NK. The VUS Challenge in Cystic Kidney Disease: A Case-Based Review. Kidney360. PMID 37962562 DOI: 10.34067/KID.0000000000000298 |
0.305 |
|
| 2023 |
Thompson WS, Babayev SN, McGowan ML, Kattah AG, Wick MJ, Bendel-Stenzel EM, Chebib FT, Harris PC, Dahl NK, Torres VE, Hanna C. State of the Science and Ethical Considerations for Preimplantation Genetic Testing for Monogenic Cystic Kidney Diseases and Ciliopathies. Journal of the American Society of Nephrology : Jasn. PMID 37882743 DOI: 10.1681/ASN.0000000000000253 |
0.335 |
|
| 2023 |
Wigerinck S, Gregory AV, Smith BH, Iliuta IA, Hanna C, Chedid M, Kaidbay HN, Senum SR, Shukoor S, Harris PC, Torres VE, Kline TL, Chebib FT. Evaluation of advanced imaging biomarkers at kidney failure in patients with ADPKD: a pilot study. Clinical Kidney Journal. 16: 1691-1700. PMID 37779848 DOI: 10.1093/ckj/sfad114 |
0.316 |
|
| 2023 |
Claus LR, Chen C, Stallworth J, Turner JL, Slaats G, Hawks AL, Mabillard H, Senum SR, Srikanth S, Flanagan-Steet H, Louie RJ, Silver J, Lerner-Ellis J, Morel C, Mighton C, ... ... Harris PC, et al. Certain heterozygous variants in the kinase domain of the serine/threonine kinase NEK8 can cause an autosomal dominant form of polycystic kidney disease. Kidney International. PMID 37598857 DOI: 10.1016/j.kint.2023.07.021 |
0.362 |
|
| 2023 |
Sieben CJ, Harris PC. Experimental Models of Polycystic Kidney Disease: Applications and Therapeutic Testing. Kidney360. PMID 37418622 DOI: 10.34067/KID.0000000000000209 |
0.396 |
|
| 2023 |
Arnous MG, Arroyo J, Cogal AG, Anglani F, Kang HG, Sas D, Harris PC, Lieske JC. The Site and Type of Genetic Variation Impact the Resulting Dent Disease-1 Phenotype. Kidney International Reports. 8: 1220-1230. PMID 37284679 DOI: 10.1016/j.ekir.2023.03.012 |
0.373 |
|
| 2023 |
Khan A, Shang N, Nestor JG, Weng C, Hripcsak G, Harris PC, Gharavi AG, Kiryluk K. Polygenic risk affects the penetrance of monogenic kidney disease. Medrxiv : the Preprint Server For Health Sciences. PMID 37214819 DOI: 10.1101/2023.05.07.23289614 |
0.338 |
|
| 2023 |
Arkhipov SN, Potter DL, Sultanova RF, Ilatovskaya DV, Harris PC, Pavlov TS. Probenecid slows disease progression in a murine model of autosomal dominant polycystic kidney disease. Physiological Reports. 11: e15652. PMID 37024297 DOI: 10.14814/phy2.15652 |
0.319 |
|
| 2023 |
Torres VE, Wang X, Quian Q, Somlo ST, Harris P, Gattone V. Will Vasopressin 2 Receptor Antagonists Prevent Autosomal Dominant Polycystic Kidney Disease?: Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med 10: 363-364, 2004. Journal of the American Society of Nephrology : Jasn. 16: 6-7. PMID 36996429 DOI: 10.1681/01.asn.0000926680.18905.68 |
0.364 |
|
| 2023 |
Gregory AV, Chebib F, Poudyal B, Holmes H, Yu ASL, Landsittel DP, Bae KT, Chapman AB, Frederic RO, Mrug M, Bennett WM, Harris PC, Erickson BJ, Torres VE, Kline TL. Utility of new image-derived biomarkers for autosomal dominant polycystic kidney disease prognosis using automated instance cyst segmentation. Kidney International. PMID 36736536 DOI: 10.1016/j.kint.2023.01.010 |
0.336 |
|
| 2022 |
Ali H, Naim M, Senum SR, AlSahow A, Bahbahani Y, Abu-Farha M, Abubaker J, Mohammad A, Al-Hunayan A, Asbeutah AM, Zayed M, Devarajan S, Hussain N, John SE, Channanath A, ... ... Harris PC, et al. The genetic landscape of autosomal dominant polycystic kidney disease in Kuwait. Clinical Kidney Journal. 16: 355-366. PMID 36755831 DOI: 10.1093/ckj/sfac236 |
0.409 |
|
| 2022 |
Chedid M, Kaidbay HD, Wigerinck S, Mkhaimer Y, Smith B, Zubidat D, Sekhon I, Prajwal R, Duriseti P, Issa N, Zoghby ZM, Hanna C, Senum SR, Harris PC, Hickson LJ, et al. Cardiovascular Outcomes in Kidney Transplant Recipients With ADPKD. Kidney International Reports. 7: 1991-2005. PMID 36090485 DOI: 10.1016/j.ekir.2022.06.006 |
0.301 |
|
| 2022 |
Lemoine H, Raud L, Foulquier F, Sayer JA, Lambert B, Olinger E, Lefèvre S, Knebelmann B, Harris PC, Trouvé P, Desprès A, Duneau G, Matignon M, Poyet A, Jourde-Chiche N, et al. Monoallelic pathogenic ALG5 variants cause atypical polycystic kidney disease and interstitial fibrosis. American Journal of Human Genetics. 109: 1484-1499. PMID 35896117 DOI: 10.1016/j.ajhg.2022.06.013 |
0.422 |
|
| 2022 |
Hanna C, Potretzke TA, Chedid M, Rangel LJ, Arroyo J, Zubidat D, Tebben PJ, Cogal AG, Torres VE, Harris PC, Sas DJ, Lieske JC, Milliner DS, Chebib FT. Kidney Cysts in Hypophosphatemic Rickets With Hypercalciuria: A Case Series. Kidney Medicine. 4: 100419. PMID 35386604 DOI: 10.1016/j.xkme.2022.100419 |
0.371 |
|
| 2022 |
Mohamed R, Liu Y, Kistler AD, Harris PC, Thangaraju M. Netrin-1 overexpression induces polycystic kidney disease - a novel mechanism contributing cystogenesis in ADPKD. The American Journal of Pathology. PMID 35358475 DOI: 10.1016/j.ajpath.2022.03.004 |
0.306 |
|
| 2022 |
Chedid M, Hanna C, Zaatari G, Mkhaimer Y, Reddy P, Rangel L, Zubidat D, Kaidbay DN, Irazabal MV, Connolly HM, Senum SR, Madsen CD, Hogan MC, Zoghby Z, Harris PC, et al. Congenital Heart Disease in Adults with Autosomal Dominant Polycystic Kidney Disease. American Journal of Nephrology. 53: 316-324. PMID 35313307 DOI: 10.1159/000522377 |
0.346 |
|
| 2022 |
Heidenreich LS, Bendel-Stenzel EM, Harris PC, Hanna C. Genetic Etiologies, Diagnosis, and Management of Neonatal Cystic Kidney Disease. Neoreviews. 23: e175-e188. PMID 35229136 DOI: 10.1542/neo.23-3-e175 |
0.376 |
|
| 2021 |
Jones BE, Mkhaimer YG, Rangel LJ, Chedid M, Schulte PJ, Mohamed AK, Neal RM, Zubidat D, Randhawa AK, Hanna C, Gregory AV, Kline TL, Zoghby ZM, Senum SR, Harris PC, et al. Asymptomatic Pyuria as a Prognostic Biomarker in Autosomal Dominant Polycystic Kidney Disease. Kidney360. 3: 465-476. PMID 35582184 DOI: 10.34067/KID.0004292021 |
0.369 |
|
| 2021 |
Singh P, Harris PC, Sas DJ, Lieske JC. The genetics of kidney stone disease and nephrocalcinosis. Nature Reviews. Nephrology. PMID 34907378 DOI: 10.1038/s41581-021-00513-4 |
0.386 |
|
| 2021 |
Senum SR, Li YSM, Benson KA, Joli G, Olinger E, Lavu S, Madsen CD, Gregory AV, Neatu R, Kline TL, Audrézet MP, Outeda P, Nau CB, Meijer E, Ali H, ... ... Harris PC, et al. Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype. American Journal of Human Genetics. PMID 34890546 DOI: 10.1016/j.ajhg.2021.11.016 |
0.431 |
|
| 2021 |
Cogal AG, Arroyo J, Shah RJ, Reese KJ, Walton BN, Reynolds LM, Kennedy GN, Seide BM, Senum SR, Baum M, Erickson SB, Jagadeesh S, Soliman NA, Goldfarb DS, Beara-Lasic L, ... ... Harris PC, et al. Comprehensive Genetic Analysis Reveals Complexity of Monogenic Urinary Stone Disease. Kidney International Reports. 6: 2862-2884. PMID 34805638 DOI: 10.1016/j.ekir.2021.08.033 |
0.312 |
|
| 2021 |
Nielsen ML, Mundt MC, Lildballe DL, Rasmussen M, Sunde L, Torres VE, Harris PC, Birn H. Functional megalin is expressed in renal cysts in a mouse model of adult polycystic kidney disease. Clinical Kidney Journal. 14: 2420-2427. PMID 34754438 DOI: 10.1093/ckj/sfab088 |
0.365 |
|
| 2021 |
Gianesello L, Arroyo J, Del Prete D, Priante G, Ceol M, Harris PC, Lieske JC, Anglani F. Genotype Phenotype Correlation in Dent Disease 2 and Review of the Literature: Gene Pleiotropism or Extreme Phenotypic Variability of Lowe Syndrome? Genes. 12. PMID 34680992 DOI: 10.3390/genes12101597 |
0.339 |
|
| 2021 |
Ding H, Li LX, Harris PC, Yang J, Li X. Extracellular vesicles and exosomes generated from cystic renal epithelial cells promote cyst growth in autosomal dominant polycystic kidney disease. Nature Communications. 12: 4548. PMID 34315885 DOI: 10.1038/s41467-021-24799-x |
0.369 |
|
| 2021 |
Hanna C, Potretzke TA, Cogal AG, Mkhaimer YG, Tebben PJ, Torres VE, Lieske JC, Harris PC, Sas DJ, Milliner DS, Chebib FT. High Prevalence of Kidney Cysts in Patients With CYP24A1 Deficiency. Kidney International Reports. 6: 1895-1903. PMID 34307984 DOI: 10.1016/j.ekir.2021.04.030 |
0.33 |
|
| 2021 |
El Ters M, Lu P, Mahnken JD, Stubbs JR, Zhang S, Wallace DP, Grantham JJ, Chapman AB, Torres VE, Harris PC, Bae KT, Landsittel DP, Rahbari-Oskoui FF, Mrug M, Bennett WM, et al. Prognostic Value of Fibroblast Growth Factor 23 in Autosomal Dominant Polycystic Kidney Disease. Kidney International Reports. 6: 953-961. PMID 33912745 DOI: 10.1016/j.ekir.2021.01.004 |
0.384 |
|
| 2021 |
Shukoor SS, Vaughan LE, Edwards ME, Lavu S, Kline TL, Senum SR, Mkhaimer Y, Zaatari G, Irazabal MV, Neal R, Hogan MC, Zoghby ZM, Harris PC, Torres VE, Chebib FT. Characteristics of Patients with End-Stage Kidney Disease in ADPKD. Kidney International Reports. 6: 755-767. PMID 33732990 DOI: 10.1016/j.ekir.2020.12.016 |
0.383 |
|
| 2021 |
Arroyo J, Escobar-Zarate D, Wells HH, Constans MM, Thao K, Smith JM, Sieben CJ, Martell MR, Kline TL, Irazabal MV, Torres VE, Hopp K, Harris PC. The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1 mouse model of autosomal dominant polycystic kidney disease. Kidney International. PMID 33705824 DOI: 10.1016/j.kint.2021.01.028 |
0.689 |
|
| 2021 |
Zhu P, Qiu Q, Harris PC, Xu X, Lin X. Haploinsufficiency Ameliorates Renal Cysts and Cilia Abnormality in Adult Zebrafish Mutants. Journal of the American Society of Nephrology : Jasn. PMID 33574160 DOI: 10.1681/ASN.2020070991 |
0.318 |
|
| 2021 |
Zhang JQJ, Saravanabavan S, Chandra AN, Munt A, Wong ATY, Harris PC, Harris DCH, McKenzie P, Wang Y, Rangan GK. Up-regulation of DNA Damage Response Signaling in Autosomal Dominant Polycystic Kidney Disease. The American Journal of Pathology. PMID 33549515 DOI: 10.1016/j.ajpath.2021.01.011 |
0.307 |
|
| 2021 |
Benson KA, Murray SL, Senum SR, Elhassan E, Conlon ET, Kennedy C, Conlon S, Gilbert E, Connaughton D, O'Hara P, Khamis S, Cormican S, Brody LC, Molloy AM, Lynch SA, ... ... Harris PC, et al. The genetic landscape of polycystic kidney disease in Ireland. European Journal of Human Genetics : Ejhg. PMID 33454723 DOI: 10.1038/s41431-020-00806-5 |
0.408 |
|
| 2020 |
Grau L, Gitomer B, McNair B, Wolf M, Harris P, Brosnahan G, Torres V, Steinman T, Yu A, Chapman A, Chonchol M, Nowak KL. Interactions between FGF23 and Genotype in Autosomal Dominant Polycystic Kidney Disease. Kidney360. 1: 648-656. PMID 33305291 DOI: 10.34067/Kid.0001692020 |
0.39 |
|
| 2020 |
Durkie M, Chong J, Valluru MK, Harris PC, Ong ACM. Biallelic inheritance of hypomorphic PKD1 variants is highly prevalent in very early onset polycystic kidney disease. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 33168999 DOI: 10.1038/s41436-020-01026-4 |
0.366 |
|
| 2020 |
Hogan MC, Chamberlin JA, Vaughan LE, Waits AL, Banks C, Leistikow K, Oftsie T, Madsen C, Edwards M, Glockner J, Kremers WK, Harris PC, LaRusso NF, Torres VE, Masyuk TV. Pansomatostatin Agonist Pasireotide Long-Acting Release for Patients with Autosomal Dominant Polycystic Kidney or Liver Disease with Severe Liver Involvement: A Randomized Clinical Trial. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 32843370 DOI: 10.2215/Cjn.13661119 |
0.356 |
|
| 2020 |
Zhang L, Li LX, Zhou JX, Harris PC, Calvet JP, Li X. RNA helicase p68 inhibits the transcription and post-transcription of in ADPKD. Theranostics. 10: 8281-8297. PMID 32724471 DOI: 10.7150/Thno.47315 |
0.382 |
|
| 2020 |
Lavu S, Vaughan LE, Senum SR, Kline TL, Chapman AB, Perrone RD, Mrug M, Braun WE, Steinman TI, Rahbari-Oskoui FF, Brosnahan GM, Bae KT, Landsittel D, Chebib FT, Yu ASL, ... ... Harris PC, et al. The value of genotypic and imaging information to predict functional and structural outcomes in ADPKD. Jci Insight. PMID 32634120 DOI: 10.1172/Jci.Insight.138724 |
0.358 |
|
| 2020 |
Huynh VT, Audrézet MP, Sayer JA, Ong AC, Lefevre S, Le Brun V, Després A, Senum SR, Chebib FT, Barroso-Gil M, Patel C, Mallett AJ, Goel H, Mallawaarachchi AC, Van Eerde AM, ... ... Harris PC, et al. Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease. Kidney International. PMID 32631624 DOI: 10.1016/J.Kint.2020.02.022 |
0.51 |
|
| 2020 |
Singh P, Chebib FT, Cogal AG, Gavrilov DK, Harris PC, Lieske JC. Pyridoxine Responsiveness in a Type 1 Primary Hyperoxaluria Patient With a Rare (Atypical) Gene Mutation. Kidney International Reports. 5: 955-958. PMID 32518881 DOI: 10.1016/J.Ekir.2020.04.004 |
0.349 |
|
| 2020 |
Bae KT, Shi T, Tao C, Yu ASL, Torres VE, Perrone RD, Chapman AB, Brosnahan G, Steinman TI, Braun WE, Srivastava A, Irazabal MV, Abebe KZ, Harris PC, Landsittel DP, et al. Expanded Imaging Classification of Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology : Jasn. PMID 32487558 DOI: 10.1681/Asn.2019101121 |
0.408 |
|
| 2020 |
Hu J, Harris PC. Regulation of polycystin expression, maturation and trafficking. Cellular Signalling. 109630. PMID 32275942 DOI: 10.1016/J.Cellsig.2020.109630 |
0.356 |
|
| 2020 |
Kahveci AS, Barnatan TT, Kahveci A, Adrian AE, Arroyo J, Eirin A, Harris PC, Lerman A, Lerman LO, Torres VE, Irazabal MV. Oxidative Stress and Mitochondrial Abnormalities Contribute to Decreased Endothelial Nitric Oxide Synthase Expression and Renal Disease Progression in Early Experimental Polycystic Kidney Disease. International Journal of Molecular Sciences. 21. PMID 32183375 DOI: 10.3390/Ijms21061994 |
0.41 |
|
| 2020 |
Kashyap S, Hein KZ, Chini CC, Lika J, Warner GM, Bale LK, Torres VE, Harris PC, Oxvig C, Conover CA, Chini EN. Metalloproteinase PAPP-A regulation of IGF-1 contributes to polycystic kidney disease pathogenesis. Jci Insight. PMID 31990681 DOI: 10.1172/Jci.Insight.135700 |
0.446 |
|
| 2019 |
Hopp K, Cornec-Le Gall E, Senum SR, Te Paske IBAW, Raj S, Lavu S, Baheti S, Edwards ME, Madsen CD, Heyer CM, Ong ACM, Bae KT, Fatica R, Steinman TI, Chapman AB, ... ... Harris PC, et al. Detection and characterization of mosaicism in autosomal dominant polycystic kidney disease. Kidney International. PMID 31874800 DOI: 10.1016/J.Kint.2019.08.038 |
0.722 |
|
| 2019 |
Jafree DJ, Moulding D, Kolatsi-Joannou M, Perretta Tejedor N, Price KL, Milmoe NJ, Walsh CL, Correra RM, Winyard PJ, Harris PC, Ruhrberg C, Walker-Samuel S, Riley PR, Woolf AS, Scambler P, et al. Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease. Elife. 8. PMID 31808745 DOI: 10.7554/Elife.48183 |
0.467 |
|
| 2019 |
Suwabe T, Shukoor S, Chamberlain AM, Killian JM, King BF, Edwards M, Senum SR, Madsen CD, Chebib FT, Hogan MC, Cornec-Le Gall E, Harris PC, Torres VE. Epidemiology of Autosomal Dominant Polycystic Kidney Disease in Olmsted County. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 31791998 DOI: 10.2215/Cjn.05900519 |
0.464 |
|
| 2019 |
Zhang JQJ, Saravanabavan S, Munt A, Wong ATY, Harris DC, Harris PC, Wang Y, Rangan GK. The role of DNA damage as a therapeutic target in autosomal dominant polycystic kidney disease. Expert Reviews in Molecular Medicine. 21: e6. PMID 31767049 DOI: 10.1017/Erm.2019.6 |
0.418 |
|
| 2019 |
Olson RJ, Hopp K, Wells H, Smith JM, Furtado J, Constans MM, Escobar DL, Geurts AM, Torres VE, Harris PC. Synergistic Genetic Interactions between and Result in an ARPKD-Like Phenotype in Murine Models. Journal of the American Society of Nephrology : Jasn. PMID 31427367 DOI: 10.1681/Asn.2019020150 |
0.735 |
|
| 2019 |
Sanchis IM, Shukoor S, Irazabal MV, Madsen CD, Chebib FT, Hogan MC, El-Zoghby Z, Harris PC, Huston J, Brown RD, Torres VE. Presymptomatic Screening for Intracranial Aneurysms in Patients with Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 31362991 DOI: 10.2215/Cjn.14691218 |
0.362 |
|
| 2019 |
Martin WP, Vaughan LE, Yoshida K, Takahashi N, Edwards ME, Metzger A, Senum SR, Masyuk TV, LaRusso NF, Griffin MD, El-Zoghby Z, Harris PC, Kremers WK, Nagorney DM, Kamath PS, et al. Bacterial Cholangitis in Autosomal Dominant Polycystic Kidney and Liver Disease. Mayo Clinic Proceedings. Innovations, Quality & Outcomes. 3: 149-159. PMID 31193902 DOI: 10.1016/J.Mayocpiqo.2019.03.004 |
0.425 |
|
| 2019 |
Gimpel C, Bergmann C, Bockenhauer D, Breysem L, Cadnapaphornchai MA, Cetiner M, Dudley J, Emma F, Konrad M, Harris T, Harris PC, König J, Liebau MC, Marlais M, Mekahli D, et al. International consensus statement on the diagnosis and management of autosomal dominant polycystic kidney disease in children and young people. Nature Reviews. Nephrology. PMID 31118499 DOI: 10.1038/S41581-019-0155-2 |
0.386 |
|
| 2019 |
McNicholas BA, Kotaro Y, Martin W, Sharma A, Kamath PS, Edwards ME, Kremers WK, Chari ST, Torres VE, Harris PC, Takahashi N, Hogan MC. Pancreatic Cysts and Intraductal Papillary Mucinous Neoplasm in Autosomal Dominant Polycystic Kidney Disease. Pancreas. 48: 698-705. PMID 31091218 DOI: 10.1097/Mpa.0000000000001306 |
0.435 |
|
| 2019 |
Bae KT, Zhou W, Shen C, Landsittel DP, Wu Z, Tao C, Chapman AB, Torres VE, Yu ASL, Mrug M, Bennett WM, Harris PC. Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 31088850 DOI: 10.2215/Cjn.10360818 |
0.454 |
|
| 2019 |
Yu ASL, Shen C, Landsittel DP, Grantham JJ, Cook LT, Torres VE, Chapman AB, Bae KT, Mrug M, Harris PC, Rahbari-Oskoui FF, Shi T, Bennett WM. Long-term trajectory of kidney function in autosomal-dominant polycystic kidney disease. Kidney International. PMID 30922668 DOI: 10.1016/J.Kint.2018.12.023 |
0.487 |
|
| 2019 |
Ali H, Al-Mulla F, Hussain N, Naim M, Asbeutah AM, AlSahow A, Abu-Farha M, Abubaker J, Al Madhoun A, Ahmad S, Harris PC. PKD1 Duplicated regions limit clinical Utility of Whole Exome Sequencing for Genetic Diagnosis of Autosomal Dominant Polycystic Kidney Disease. Scientific Reports. 9: 4141. PMID 30858458 DOI: 10.1038/S41598-019-40761-W |
0.473 |
|
| 2019 |
Beara-Lasic L, Cogal A, Mara K, Enders F, Mehta RA, Haskic Z, Furth SL, Trachtman H, Scheinman SJ, Milliner DS, Goldfarb DS, Harris PC, Lieske JC. Prevalence of low molecular weight proteinuria and Dent disease 1 CLCN5 mutations in proteinuric cohorts. Pediatric Nephrology (Berlin, Germany). PMID 30852663 DOI: 10.1007/S00467-019-04210-0 |
0.437 |
|
| 2019 |
Yoshida K, Takahashi N, King BF, Kawashima A, Harris PC, Cornell LD, Cornec-Le Gall E, Inoue D, Mizushima I, Kawano M, Thervet E, de Cotret PR, Torres VE. Multiple unilateral subcapsular cortical hemorrhagic cystic disease of the kidney: CT and MRI findings and clinical characteristic. European Radiology. PMID 30806804 DOI: 10.1007/S00330-019-06057-3 |
0.388 |
|
| 2019 |
Torres VE, Harris PC. Progress in the understanding of polycystic kidney disease. Nature Reviews. Nephrology. PMID 30607031 DOI: 10.1038/S41581-018-0108-1 |
0.448 |
|
| 2019 |
Jafree DJ, Moulding D, Kolatsi-Joannou M, Tejedor NP, Price KL, Milmoe NJ, Walsh CL, Correra RM, Winyard PJ, Harris PC, Ruhrberg C, Walker-Samuel S, Riley PR, Woolf AS, Scambler PJ, et al. Author response: Spatiotemporal dynamics and heterogeneity of renal lymphatics in mammalian development and cystic kidney disease Elife. DOI: 10.7554/Elife.48183.Sa2 |
0.451 |
|
| 2018 |
McKenzie KA, El Ters M, Torres VE, Harris PC, Chapman AB, Mrug M, Rahbari-Oskoui FF, Bae KT, Landsittel DP, Bennett WM, Yu ASL, Mahnken JD. Relationship between caffeine intake and autosomal dominant polycystic kidney disease progression: a retrospective analysis using the CRISP cohort. Bmc Nephrology. 19: 378. PMID 30591038 DOI: 10.1186/S12882-018-1182-0 |
0.484 |
|
| 2018 |
Sas DJ, Harris PC, Milliner DS. Recent advances in the identification and management of inherited hyperoxalurias. Urolithiasis. PMID 30535828 DOI: 10.1007/S00240-018-1093-3 |
0.446 |
|
| 2018 |
Bergmann C, Guay-Woodford LM, Harris PC, Horie S, Peters DJM, Torres VE. Polycystic kidney disease. Nature Reviews. Disease Primers. 4: 50. PMID 30523303 DOI: 10.1038/s41572-018-0047-y |
0.422 |
|
| 2018 |
Mallawaarachchi AC, Furlong TJ, Shine J, Harris PC, Cowley MJ. Population data improves variant interpretation in autosomal dominant polycystic kidney disease. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 30369598 DOI: 10.1038/S41436-018-0324-X |
0.475 |
|
| 2018 |
Kleczko EK, Marsh KH, Tyler LC, Furgeson SB, Bullock BL, Altmann CJ, Miyazaki M, Gitomer BY, Harris PC, Weiser-Evans MCM, Chonchol MB, Clambey ET, Nemenoff RA, Hopp K. CD8 T cells modulate autosomal dominant polycystic kidney disease progression. Kidney International. PMID 30249452 DOI: 10.1016/J.Kint.2018.06.025 |
0.646 |
|
| 2018 |
Chebib FT, Perrone RD, Chapman AB, Dahl NK, Harris PC, Mrug M, Mustafa RA, Rastogi A, Watnick T, Yu ASL, Torres VE. A Practical Guide for Treatment of Rapidly Progressive ADPKD with Tolvaptan. Journal of the American Society of Nephrology : Jasn. PMID 30228150 DOI: 10.1681/Asn.2018060590 |
0.344 |
|
| 2018 |
Lanktree MB, Haghighi A, Guiard E, Iliuta IA, Song X, Harris PC, Paterson AD, Pei Y. Prevalence Estimates of Polycystic Kidney and Liver Disease by Population Sequencing. Journal of the American Society of Nephrology : Jasn. PMID 30135240 DOI: 10.1681/Asn.2018050493 |
0.342 |
|
| 2018 |
Boczek NJ, Hopp K, Benoit L, Kraft D, Cousin MA, Blackburn PR, Madsen CD, Oliver GR, Nair AA, Na J, Bianchi DW, Beek G, Harris PC, Pichurin P, Klee EW. Characterization of three ciliopathy pedigrees expands the phenotype associated with biallelic C2CD3 variants. European Journal of Human Genetics : Ejhg. PMID 30097616 DOI: 10.1038/S41431-018-0222-3 |
0.687 |
|
| 2018 |
Harris PC. The time for next-generation molecular genetic diagnostics in nephrology is now! Kidney International. 94: 237-239. PMID 30031442 DOI: 10.1016/J.Kint.2018.03.025 |
0.386 |
|
| 2018 |
Edwards ME, Chebib FT, Irazabal MV, Ofstie TG, Bungum LA, Metzger AJ, Senum SR, Hogan MC, El-Zoghby ZM, Kline TL, Harris PC, Czerwiec FS, Torres VE. Long-Term Administration of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 30026287 DOI: 10.2215/Cjn.01520218 |
0.421 |
|
| 2018 |
Cornec-Le Gall E, Harris PC. The Underestimated Burden of Monogenic Diseases in Adult-Onset ESRD. Journal of the American Society of Nephrology : Jasn. PMID 29769229 DOI: 10.1681/Asn.2018040441 |
0.394 |
|
| 2018 |
Cornec-Le Gall E, Olson RJ, Besse W, Heyer CM, Gainullin VG, Smith JM, Audrézet MP, Hopp K, Porath B, Shi B, Baheti S, Senum SR, Arroyo J, Madsen CD, Férec C, ... ... Harris PC, et al. Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease. American Journal of Human Genetics. PMID 29706351 DOI: 10.1016/J.Ajhg.2018.03.013 |
0.757 |
|
| 2018 |
Brosnahan GM, Abebe KZ, Moore CG, Bae KT, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Rahbari-Oskoui FF, Steinman TI, Torres VE, The Halt Pkd Investigators. Determinants of Progression in Early Autosomal Dominant Polycystic Kidney Disease - Is it Blood Pressure or Renin-Angiotensin-Aldosterone-System Blockade? Current Hypertension Reviews. PMID 29564978 DOI: 10.2174/1573402114666180322110209 |
0.326 |
|
| 2018 |
Cornec-Le Gall E, Chebib FT, Madsen CD, Senum SR, Heyer CM, Lanpher BC, Patterson MC, Albright RC, Yu AS, Torres VE, Harris PC. The Value of Genetic Testing in Polycystic Kidney Diseases Illustrated by a Family With PKD2 and COL4A1 Mutations. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 29395486 DOI: 10.1053/J.Ajkd.2017.11.015 |
0.521 |
|
| 2018 |
de Stephanis L, Mangolini A, Servello M, Harris PC, Dell'Atti L, Pinton P, Aguiari G. MicroRNA501-5p induces p53 proteasome degradation through the activation of the mTOR/MDM2 pathway in ADPKD cells. Journal of Cellular Physiology. PMID 29323708 DOI: 10.1002/Jcp.26473 |
0.344 |
|
| 2018 |
Brosnahan GM, Abebe KZ, Moore CG, Rahbari-Oskoui FF, Bae KT, Grantham JJ, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Hogan MC, Perrone RD, Miskulin DC, Steinman TI, et al. Patterns of Kidney Function Decline in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis From the HALT-PKD Trials. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 29306517 DOI: 10.1053/j.ajkd.2017.10.023 |
0.355 |
|
| 2018 |
Kahveci A, Chebib FT, Eirin A, Lerman A, Lerman LO, Harris PC, Torres VE, Irazabal MV. Abstract 124: Nadph Oxidase 4 and Mitochondrial Abnormalities Contribute to Oxidative Stress and Endothelial Dysfunction in Young Normotensive Patients With Autosomal Dominant Polycystic Kidney Disease Hypertension. 72. DOI: 10.1161/Hyp.72.Suppl_1.124 |
0.339 |
|
| 2018 |
Martin W, Cornec Le-Gall E, Salameh H, McNicholas B, Griffin M, Fervenza F, Harris P, Cornell L, Hogan M. SP003GENETIC TESTING IN SUSPECTED HEREDITARY PROTEINURIC KIDNEY DISEASES Nephrology Dialysis Transplantation. 33: i346-i347. DOI: 10.1093/Ndt/Gfy104.Sp003 |
0.435 |
|
| 2017 |
Yu ASL, Shen C, Landsittel DP, Harris PC, Torres VE, Mrug M, Bae KT, Grantham JJ, Rahbari-Oskoui FF, Flessner MF, Bennett WM, Chapman AB. Baseline total kidney volume and the rate of kidney growth are associated with chronic kidney disease progression in Autosomal Dominant Polycystic Kidney Disease. Kidney International. PMID 29290310 DOI: 10.1016/J.Kint.2017.09.027 |
0.443 |
|
| 2017 |
Chebib FT, Hogan MC, El-Zoghby ZM, Irazabal MV, Senum SR, Heyer CM, Madsen CD, Cornec-Le Gall E, Behfar A, Harris PC, Torres VE. Autosomal Dominant Polycystic Kidney Patients May Be Predisposed to Various Cardiomyopathies. Kidney International Reports. 2: 913-923. PMID 29270497 DOI: 10.1016/J.Ekir.2017.05.014 |
0.476 |
|
| 2017 |
Braun WE, Abebe KZ, Brosnahan G, Patterson CG, Chapman AB, Harris PC, Hogan MC, Perrone RD, Torres VE, Miskulin DC, Steinman TI, Winklhofer FT, Rahbari-Oskoui FF, Czarnecki PG, Bae KT, et al. ADPKD Progression in Patients With No Apparent Family History and No Mutation Detected by Sanger Sequencing. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 29203126 DOI: 10.1053/J.Ajkd.2017.09.008 |
0.35 |
|
| 2017 |
Cornec-Le Gall E, Torres VE, Harris PC. Genetic Complexity of Autosomal Dominant Polycystic Kidney and Liver Diseases. Journal of the American Society of Nephrology : Jasn. PMID 29038287 DOI: 10.1681/Asn.2017050483 |
0.483 |
|
| 2017 |
Cornec-Le Gall E, Blais JD, Irazabal MV, Devuyst O, Gansevoort RT, Perrone RD, Chapman AB, Czerwiec FS, Ouyang J, Heyer CM, Senum SR, Le Meur Y, Torres VE, Harris PC. Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 28992127 DOI: 10.1093/Ndt/Gfx188 |
0.444 |
|
| 2017 |
Higashihara E, Horie S, Kinoshita M, Harris PC, Okegawa T, Tanbo M, Hara H, Yamaguchi T, Shigemori K, Kawano H, Miyazaki I, Kaname S, Nutahara K. A potentially crucial role of the PKD1 C-terminal tail in renal prognosis. Clinical and Experimental Nephrology. PMID 28983800 DOI: 10.1007/S10157-017-1477-7 |
0.471 |
|
| 2017 |
Wang X, Yamada S, LaRiviere WB, Ye H, Bakeberg JL, Irazabal MV, Chebib FT, van Deursen J, Harris PC, Sussman CR, Behfar A, Ward CJ, Torres VE. Generation and phenotypic characterization of Pde1a mutant mice. Plos One. 12: e0181087. PMID 28750036 DOI: 10.1371/Journal.Pone.0181087 |
0.446 |
|
| 2017 |
Kline TL, Edwards ME, Garg I, Irazabal MV, Korfiatis P, Harris PC, King BF, Torres VE, Venkatesh SK, Erickson BJ. Quantitative MRI of kidneys in renal disease. Abdominal Radiology (New York). PMID 28660330 DOI: 10.1007/S00261-017-1236-Y |
0.457 |
|
| 2017 |
Ye H, Wang X, Constans MM, Sussman CR, Chebib F, Irazabal MV, Young WF, Harris PC, Kirschner LS, Torres VE. The Regulatory 1α Subunit of Protein Kinase A Modulates Renal Cystogenesis. American Journal of Physiology. Renal Physiology. ajprenal.00119.2017. PMID 28615245 DOI: 10.1152/Ajprenal.00119.2017 |
0.48 |
|
| 2017 |
Kline TL, Korfiatis P, Edwards ME, Blais JD, Czerwiec FS, Harris PC, King BF, Torres VE, Erickson BJ. Performance of an Artificial Multi-observer Deep Neural Network for Fully Automated Segmentation of Polycystic Kidneys. Journal of Digital Imaging. PMID 28550374 DOI: 10.1007/S10278-017-9978-1 |
0.319 |
|
| 2017 |
Kline TL, Korfiatis P, Edwards ME, Bae KT, Yu A, Chapman AB, Mrug M, Grantham JJ, Landsittel D, Bennett WM, King BF, Harris PC, Torres VE, Erickson BJ. Image texture features predict renal function decline in patients with autosomal dominant polycystic kidney disease. Kidney International. PMID 28532709 DOI: 10.1016/J.Kint.2017.03.026 |
0.376 |
|
| 2017 |
Iliuta IA, Kalatharan V, Wang K, Cornec-Le Gall E, Conklin J, Pourafkari M, Ting R, Chen C, Borgo AC, He N, Song X, Heyer CM, Senum SR, Hwang YH, Paterson AD, ... Harris PC, et al. Polycystic Kidney Disease without an Apparent Family History. Journal of the American Society of Nephrology : Jasn. PMID 28522688 DOI: 10.1681/Asn.2016090938 |
0.507 |
|
| 2017 |
Brosnahan G, Abebe KZ, Rahbari-Oskoui FF, Patterson CG, Bae KT, Schrier RW, Braun WE, Chapman AB, Flessner MF, Harris PC, Perrone RD, Steinman TI, Torres VE, The Halt Pkd Investigators. Effect of statin therapy on the progression of autosomal dominant polycystic kidney disease. A secondary analysis of the HALT PKD trials. Current Hypertension Reviews. PMID 28460625 DOI: 10.2174/1573402113666170427142815 |
0.445 |
|
| 2017 |
Holditch SJ, Schreiber CA, Harris PC, LaRusso NF, Ramirez-Alvarado M, Cataliotti A, Torres VE, Ikeda Y. B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease. Kidney International. PMID 28416225 DOI: 10.1016/J.Kint.2017.02.017 |
0.478 |
|
| 2017 |
Cornec-Le Gall E, Audrézet MP, Renaudineau E, Hourmant M, Charasse C, Michez E, Frouget T, Vigneau C, Dantal J, Siohan P, Longuet H, Gatault P, Ecotière L, Bridoux F, Mandart L, ... ... Harris PC, et al. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. PMID 28356211 DOI: 10.1053/J.Ajkd.2017.01.046 |
0.49 |
|
| 2017 |
Hajarnis S, Lakhia R, Yheskel M, Williams D, Sorourian M, Liu X, Aboudehen K, Zhang S, Kersjes K, Galasso R, Li J, Kaimal V, Lockton S, Davis S, Flaten A, ... ... Harris PC, et al. microRNA-17 family promotes polycystic kidney disease progression through modulation of mitochondrial metabolism. Nature Communications. 8: 14395. PMID 28205547 DOI: 10.1038/Ncomms14395 |
0.317 |
|
| 2017 |
Yin M, Glaser KJ, Manduca A, Mounajjed T, Malhi H, Simonetto DA, Wang R, Yang L, Mao SA, Glorioso JM, Elgilani FM, Ward CJ, Harris PC, Nyberg SL, Shah VH, et al. Distinguishing between Hepatic Inflammation and Fibrosis with MR Elastography. Radiology. 160622. PMID 28128707 DOI: 10.1148/Radiol.2017160622 |
0.303 |
|
| 2017 |
Streets AJ, Magayr TA, Huang L, Vergoz L, Rossetti S, Simms RJ, Harris PC, Peters DJ, Ong AC. Parallel microarray profiling identifies ErbB4 as a determinant of cyst growth in ADPKD and a prognostic biomarker for disease progression. American Journal of Physiology. Renal Physiology. ajprenal.00607.2016. PMID 28077374 DOI: 10.1152/Ajprenal.00607.2016 |
0.48 |
|
| 2017 |
Gall EC, Heyer C, Senum S, Audrézet M, Meur YL, Torres V, Harris P. So029Identifying The Culprit Gene In 400 Genetically Unresolved Autosomal Dominant Polycystic Kidney Or Liver Disease (Adpkd/Adpld) Pedigrees Nephrology Dialysis Transplantation. 32. DOI: 10.1093/Ndt/Gfx136 |
0.449 |
|
| 2016 |
Irazabal MV, Blais JD, Perrone RD, Gansevoort RT, Chapman AB, Devuyst O, Higashihara E, Harris PC, Zhou W, Ouyang J, Czerwiec FS, Torres VE. Prognostic Enrichment Design in Clinical Trials for Autosomal Dominant Polycystic Kidney Disease: The TEMPO 3:4 Clinical Trial. Kidney International Reports. 1: 213-220. PMID 29142926 DOI: 10.1016/J.Ekir.2016.08.001 |
0.351 |
|
| 2016 |
Duran D, Jin SC, DeSpenza T, Nelson-Williams C, Cogal AG, Abrash EW, Harris PC, Lieske JC, Shimshak SJ, Mane S, Bilguvar K, DiLuna ML, Günel M, Lifton RP, Kahle KT. Digenic mutations of human OCRL paralogs in Dent's disease type 2 associated with Chiari I malformation. Human Genome Variation. 3: 16042. PMID 28018608 DOI: 10.1038/Hgv.2016.42 |
0.44 |
|
| 2016 |
Zhu P, Sieben CJ, Xu X, Harris PC, Lin X. Autophagy Activators Suppress Cystogenesis in an Autosomal Dominant Polycystic Kidney Disease Model. Human Molecular Genetics. PMID 28007903 DOI: 10.1093/Hmg/Ddw376 |
0.459 |
|
| 2016 |
de Almeida RM, Clendenon SG, Richards WG, Boedigheimer M, Damore M, Rossetti S, Harris PC, Herbert BS, Xu WM, Wandinger-Ness A, Ward HH, Glazier JA, Bacallao RL. Transcriptome analysis reveals manifold mechanisms of cyst development in ADPKD. Human Genomics. 10: 37. PMID 27871310 DOI: 10.1186/S40246-016-0095-X |
0.534 |
|
| 2016 |
Wang X, Anglani F, Beara-Lasic L, Mehta AJ, Vaughan LE, Herrera Hernandez L, Cogal A, Scheinman SJ, Ariceta G, Isom R, Copelovitch L, Enders FT, Del Prete D, Vezzoli G, Paglialonga F, ... Harris PC, et al. Glomerular Pathology in Dent Disease and Its Association with Kidney Function. Clinical Journal of the American Society of Nephrology : Cjasn. PMID 27697782 DOI: 10.2215/Cjn.03710416 |
0.487 |
|
| 2016 |
Irazabal MV, Abebe KZ, Bae KT, Perrone RD, Chapman AB, Schrier RW, Yu AS, Braun WE, Steinman TI, Harris PC, Flessner MF, Torres VE. Prognostic enrichment design in clinical trials for autosomal dominant polycystic kidney disease: the HALT-PKD clinical trial. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 27484667 DOI: 10.1093/Ndt/Gfw294 |
0.357 |
|
| 2016 |
Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, Edwards ME, Madsen CD, Mauritz SR, Banks CJ, Baheti S, Reddy B, Herrero JI, Bañales JM, Hogan MC, ... ... Harris PC, et al. Mutations in GANAB, Encoding the Glucosidase IIα Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease. American Journal of Human Genetics. 98: 1193-1207. PMID 27259053 DOI: 10.1016/J.Ajhg.2016.05.004 |
0.751 |
|
| 2016 |
Kim B, King BF, Vrtiska TJ, Irazabal MV, Torres VE, Harris PC. Inherited renal cystic diseases. Abdominal Radiology (New York). PMID 27167233 DOI: 10.1007/S00261-016-0754-3 |
0.517 |
|
| 2016 |
Tang X, Brown MR, Cogal AG, Gauvin D, Harris PC, Lieske JC, Romero MF, Chang MH. Functional and transport analyses of CLCN5 genetic changes identified in Dent disease patients. Physiological Reports. 4. PMID 27117801 DOI: 10.14814/Phy2.12776 |
0.432 |
|
| 2016 |
Chebib FT, Jung Y, Heyer CM, Irazabal MV, Hogan MC, Harris PC, Torres VE, El-Zoghby ZM. Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 26932689 DOI: 10.1093/Ndt/Gfw008 |
0.472 |
|
| 2016 |
Heyer CM, Sundsbak JL, Abebe KZ, Chapman AB, Torres VE, Grantham JJ, Bae KT, Schrier RW, Perrone RD, Braun WE, Steinman TI, Mrug M, Yu AS, Brosnahan G, Hopp K, ... ... Harris PC, et al. Predicted Mutation Strength of Nontruncating PKD1 Mutations Aids Genotype-Phenotype Correlations in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology : Jasn. PMID 26823553 DOI: 10.1681/Asn.2015050583 |
0.717 |
|
| 2015 |
Hogan MC, Lieske JC, Lienczewski CC, Nesbitt LL, Wickman LT, Heyer CM, Harris PC, Ward CJ, Sundsbak JL, Manganelli L, Ju W, Kopp JB, Nelson PJ, Adler SG, Reich HN, et al. Strategy and rationale for urine collection protocols employed in the NEPTUNE study. Bmc Nephrology. 16: 190. PMID 26577187 DOI: 10.1186/S12882-015-0185-3 |
0.394 |
|
| 2015 |
Warner G, Hein KZ, Nin V, Edwards M, Chini CC, Hopp K, Harris PC, Torres VE, Chini EN. Food Restriction Ameliorates the Development of Polycystic Kidney Disease. Journal of the American Society of Nephrology : Jasn. PMID 26538633 DOI: 10.1681/Asn.2015020132 |
0.719 |
|
| 2015 |
Hwang YH, Conklin J, Chan W, Roslin NM, Liu J, He N, Wang K, Sundsbak JL, Heyer CM, Haider M, Paterson AD, Harris PC, Pei Y. Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease. Journal of the American Society of Nephrology : Jasn. PMID 26453610 DOI: 10.1681/Asn.2015060648 |
0.517 |
|
| 2015 |
Ye H, Wang X, Sussman CR, Hopp K, Irazabal MV, Bakeberg JL, LaRiviere WB, Manganiello VC, Voorhees CV, Zhao H, Harris PC, van Deursen J, Ward CJ, Torres VE. Modulation of Polycystic Kidney Disease Severity by Phosphodiesterase 1 and 3 Subfamilies. Journal of the American Society of Nephrology : Jasn. PMID 26374610 DOI: 10.1681/Asn.2015010057 |
0.684 |
|
| 2015 |
Moore CG, Spillane S, Simon G, Maxwell B, Rahbari-Oskoui FF, Braun WE, Chapman AB, Schrier RW, Torres VE, Perrone RD, Steinman TI, Brosnahan G, Czarnecki PG, Harris PC, Miskulin DC, et al. Closeout of the HALT-PKD trials. Contemporary Clinical Trials. 44: 48-55. PMID 26231556 DOI: 10.1016/J.Cct.2015.07.017 |
0.309 |
|
| 2015 |
Ong AC, Harris PC. A polycystin-centric view of cyst formation and disease: the polycystins revisited. Kidney International. 88: 699-710. PMID 26200945 DOI: 10.1038/Ki.2015.207 |
0.479 |
|
| 2015 |
Cabrera-López C, Bullich G, Martí T, Català V, Ballarín J, Bissler JJ, Harris PC, Ars E, Torra R. Insight into response to mTOR inhibition when PKD1 and TSC2 are mutated. Bmc Medical Genetics. 16: 39. PMID 26077033 DOI: 10.1186/S12881-015-0185-Y |
0.508 |
|
| 2015 |
Jung Y, Irazabal MV, Chebib FT, Harris PC, Dean PG, Prieto M, Cosio FG, El-Zoghby ZM, Torres VE. Volume regression of native polycystic kidneys after renal transplantation. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. PMID 26044834 DOI: 10.1093/Ndt/Gfv227 |
0.43 |
|
| 2015 |
Kline TL, Irazabal MV, Ebrahimi B, Hopp K, Udoji KN, Warner JD, Korfiatis P, Mishra PK, Macura SI, Venkatesh SK, Lerman LO, Harris PC, Torres VE, King BF, Erickson BJ. Utilizing magnetization transfer imaging to investigate tissue remodeling in a murine model of autosomal dominant polycystic kidney disease. Magnetic Resonance in Medicine : Official Journal of the Society of Magnetic Resonance in Medicine / Society of Magnetic Resonance in Medicine. PMID 25974140 DOI: 10.1002/Mrm.25701 |
0.678 |
|
| 2015 |
Antignac C, Calvet JP, Germino GG, Grantham JJ, Guay-Woodford LM, Harris PC, Hildebrandt F, Peters DJ, Somlo S, Torres VE, Walz G, Zhou J, Yu AS. The Future of Polycystic Kidney Disease Research-As Seen By the 12 Kaplan Awardees. Journal of the American Society of Nephrology : Jasn. PMID 25952256 DOI: 10.1681/Asn.2014121192 |
0.394 |
|
| 2015 |
Ali H, Hussain N, Naim M, Zayed M, Al-Mulla F, Kehinde EO, Seaburg LM, Sundsbak JL, Harris PC. A novel PKD1 variant demonstrates a disease-modifying role in trans with a truncating PKD1 mutation in patients with autosomal dominant polycystic kidney disease. Bmc Nephrology. 16: 26. PMID 25880449 DOI: 10.1186/S12882-015-0015-7 |
0.536 |
|
| 2015 |
Chebib FT, Sussman CR, Wang X, Harris PC, Torres VE. Vasopressin and disruption of calcium signalling in polycystic kidney disease. Nature Reviews. Nephrology. PMID 25870007 DOI: 10.1038/Nrneph.2015.39 |
0.478 |
|
| 2015 |
Hopp K, Cogal AG, Bergstralh EJ, Seide BM, Olson JB, Meek AM, Lieske JC, Milliner DS, Harris PC. Phenotype-Genotype Correlations and Estimated Carrier Frequencies of Primary Hyperoxaluria. Journal of the American Society of Nephrology : Jasn. PMID 25644115 DOI: 10.1681/Asn.2014070698 |
0.631 |
|
| 2015 |
Gainullin VG, Hopp K, Ward CJ, Hommerding CJ, Harris PC. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner. The Journal of Clinical Investigation. 125: 607-20. PMID 25574838 DOI: 10.1172/Jci76972 |
0.701 |
|
| 2015 |
Schueler M, Braun DA, Chandrasekar G, Gee HY, Klasson TD, Halbritter J, Bieder A, Porath JD, Airik R, Zhou W, LoTurco JJ, Che A, Otto EA, Böckenhauer D, Sebire NJ, ... ... Harris PC, et al. DCDC2 mutations cause a renal-hepatic ciliopathy by disrupting Wnt signaling. American Journal of Human Genetics. 96: 81-92. PMID 25557784 DOI: 10.1016/J.Ajhg.2014.12.002 |
0.47 |
|
| 2015 |
Hopp K, Wang X, Ye H, Irazabal MV, Harris PC, Torres VE. Effects of hydration in rats and mice with polycystic kidney disease. American Journal of Physiology. Renal Physiology. 308: F261-6. PMID 25503729 DOI: 10.1152/Ajprenal.00345.2014 |
0.669 |
|
| 2015 |
Hogan MC, Bakeberg JL, Gainullin VG, Irazabal MV, Harmon AJ, Lieske JC, Charlesworth MC, Johnson KL, Madden BJ, Zenka RM, McCormick DJ, Sundsbak JL, Heyer CM, Torres VE, Harris PC, et al. Identification of Biomarkers for PKD1 Using Urinary Exosomes. Journal of the American Society of Nephrology : Jasn. 26: 1661-70. PMID 25475747 DOI: 10.1681/Asn.2014040354 |
0.428 |
|
| 2015 |
Pei Y, Hwang YH, Conklin J, Sundsbak JL, Heyer CM, Chan W, Wang K, He N, Rattansingh A, Atri M, Harris PC, Haider MA. Imaging-based diagnosis of autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 26: 746-53. PMID 25074509 DOI: 10.1681/Asn.2014030297 |
0.342 |
|
| 2015 |
Hopp K, Hommerding CJ, Wang X, Ye H, Harris PC, Torres VE. Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model. Journal of the American Society of Nephrology : Jasn. 26: 39-47. PMID 24994926 DOI: 10.1681/Asn.2013121312 |
0.674 |
|
| 2015 |
Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, Bae KT, Chapman AB, Grantham JJ, Mrug M, Hogan MC, El-Zoghby ZM, Harris PC, Erickson BJ, King BF, et al. Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials. Journal of the American Society of Nephrology : Jasn. 26: 160-72. PMID 24904092 DOI: 10.1681/Asn.2013101138 |
0.351 |
|
| 2014 |
Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, et al. Blood pressure in early autosomal dominant polycystic kidney disease. The New England Journal of Medicine. 371: 2255-66. PMID 25399733 DOI: 10.1056/Nejmoa1402685 |
0.479 |
|
| 2014 |
Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, Winklhofer FT, Brosnahan G, Czarnecki PG, Hogan MC, Miskulin DC, Rahbari-Oskoui FF, Grantham JJ, Harris PC, Flessner MF, et al. Angiotensin blockade in late autosomal dominant polycystic kidney disease. The New England Journal of Medicine. 371: 2267-76. PMID 25399731 DOI: 10.1056/Nejmoa1402686 |
0.41 |
|
| 2014 |
Franchi F, Peterson KM, Xu R, Miller B, Psaltis PJ, Harris PC, Lerman LO, Rodriguez-Porcel M. Mesenchymal stromal cells improve renovascular function in Polycystic Kidney Disease. Cell Transplantation. PMID 25290249 DOI: 10.3727/096368914X684619 |
0.344 |
|
| 2014 |
Harris PC, Torres VE. Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease. The Journal of Clinical Investigation. 124: 2315-24. PMID 24892705 DOI: 10.1172/Jci72272 |
0.466 |
|
| 2014 |
Sussman CR, Ward CJ, Leightner AC, Smith JL, Agarwal R, Harris PC, Torres VE. Phosphodiesterase 1A modulates cystogenesis in zebrafish. Journal of the American Society of Nephrology : Jasn. 25: 2222-30. PMID 24700876 DOI: 10.1681/Asn.2013040421 |
0.79 |
|
| 2014 |
Torres VE, Harris PC. Strategies targeting cAMP signaling in the treatment of polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 25: 18-32. PMID 24335972 DOI: 10.1681/Asn.2013040398 |
0.408 |
|
| 2014 |
Paul BM, Consugar MB, Ryan Lee M, Sundsbak JL, Heyer CM, Rossetti S, Kubly VJ, Hopp K, Torres VE, Coto E, Clementi M, Bogdanova N, de Almeida E, Bichet DG, Harris PC. Evidence of a third ADPKD locus is not supported by re-analysis of designated PKD3 families. Kidney International. 85: 383-92. PMID 23760289 DOI: 10.1038/Ki.2013.227 |
0.682 |
|
| 2014 |
Cabrera-Lopez C, Ars E, Marti T, Harris PC, Torra R, Clerckx C, Migeon T, Chen Z, Ronco P, Plaisier E, Lamers IJ, Van Reeuwijk J, Azam M, Boldt K, Maria M, et al. RENAL DEVELOPMENT AND CYSTIC DISEASES Nephrology Dialysis Transplantation. 29: iii73-iii78. DOI: 10.1093/Ndt/Gfu141 |
0.478 |
|
| 2013 |
Vazifehmand R, Rossetti S, Saber S, Khorshid HR, Harris PC. Molecular analysis of a consanguineous Iranian polycystic kidney disease family identifies a PKD2 mutation that aids diagnostics. Bmc Nephrology. 14: 190. PMID 24011172 DOI: 10.1186/1471-2369-14-190 |
0.512 |
|
| 2013 |
Freedman BS, Lam AQ, Sundsbak JL, Iatrino R, Su X, Koon SJ, Wu M, Daheron L, Harris PC, Zhou J, Bonventre JV. Reduced ciliary polycystin-2 in induced pluripotent stem cells from polycystic kidney disease patients with PKD1 mutations. Journal of the American Society of Nephrology : Jasn. 24: 1571-86. PMID 24009235 DOI: 10.1681/Asn.2012111089 |
0.41 |
|
| 2013 |
Peterson KM, Franchi F, Loeffler DL, Psaltis PJ, Harris PC, Lerman LO, Lerman A, Rodriguez-Porcel M. Endothelial dysfunction occurs prior to clinical evidence of polycystic kidney disease. American Journal of Nephrology. 38: 233-40. PMID 24008943 DOI: 10.1159/000354236 |
0.458 |
|
| 2013 |
Rossetti S, Harris PC. The genetics of vascular complications in autosomal dominant polycystic kidney disease (ADPKD). Current Hypertension Reviews. 9: 37-43. PMID 23971643 DOI: 10.2174/1573402111309010007 |
0.454 |
|
| 2013 |
Hoff S, Halbritter J, Epting D, Frank V, Nguyen TM, van Reeuwijk J, Boehlke C, Schell C, Yasunaga T, Helmstädter M, Mergen M, Filhol E, Boldt K, Horn N, Ueffing M, ... ... Harris PC, et al. ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Nature Genetics. 45: 951-6. PMID 23793029 DOI: 10.1038/Ng.2681 |
0.502 |
|
| 2013 |
Harris PC, Hopp K. The mutation, a key determinant of phenotype in ADPKD. Journal of the American Society of Nephrology : Jasn. 24: 868-70. PMID 23687354 DOI: 10.1681/Asn.2013040417 |
0.728 |
|
| 2013 |
Leightner AC, Hommerding CJ, Peng Y, Salisbury JL, Gainullin VG, Czarnecki PG, Sussman CR, Harris PC. The Meckel syndrome protein meckelin (TMEM67) is a key regulator of cilia function but is not required for tissue planar polarity. Human Molecular Genetics. 22: 2024-40. PMID 23393159 DOI: 10.1093/Hmg/Ddt054 |
0.792 |
|
| 2013 |
Herbert BS, Grimes BR, Xu WM, Werner M, Ward C, Rossetti S, Harris P, Bello-Reuss E, Ward HH, Miller C, Gattone VH, Phillips CL, Wandinger-Ness A, Bacallao RL. A telomerase immortalized human proximal tubule cell line with a truncation mutation (Q4004X) in polycystin-1. Plos One. 8: e55191. PMID 23383103 DOI: 10.1371/Journal.Pone.0055191 |
0.414 |
|
| 2013 |
Paavola J, Schliffke S, Rossetti S, Kuo IY, Yuan S, Sun Z, Harris PC, Torres VE, Ehrlich BE. Polycystin-2 mutations lead to impaired calcium cycling in the heart and predispose to dilated cardiomyopathy. Journal of Molecular and Cellular Cardiology. 58: 199-208. PMID 23376035 DOI: 10.1016/J.Yjmcc.2013.01.015 |
0.392 |
|
| 2013 |
Xu R, Franchi F, Miller B, Crane JA, Peterson KM, Psaltis PJ, Harris PC, Lerman LO, Rodriguez-Porcel M. Polycystic kidneys have decreased vascular density: a micro-CT study. Microcirculation (New York, N.Y. : 1994). 20: 183-9. PMID 23167921 DOI: 10.1111/Micc.12022 |
0.42 |
|
| 2012 |
Hopp K, Ward CJ, Hommerding CJ, Nasr SH, Tuan HF, Gainullin VG, Rossetti S, Torres VE, Harris PC. Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity. The Journal of Clinical Investigation. 122: 4257-73. PMID 23064367 DOI: 10.1172/Jci64313 |
0.747 |
|
| 2012 |
Wang X, Ye H, Ward CJ, Chu JY, Masyuk TV, Larusso NF, Harris PC, Chow BK, Torres VE. Insignificant effect of secretin in rodent models of polycystic kidney and liver disease. American Journal of Physiology. Renal Physiology. 303: F1089-98. PMID 22811488 DOI: 10.1152/Ajprenal.00242.2012 |
0.416 |
|
| 2012 |
Aguiari G, Bizzarri F, Bonon A, Mangolini A, Magri E, Pedriali M, Querzoli P, Somlo S, Harris PC, Catizone L, Del Senno L. Polycystin-1 regulates amphiregulin expression through CREB and AP1 signalling: implications in ADPKD cell proliferation. Journal of Molecular Medicine (Berlin, Germany). 90: 1267-82. PMID 22570239 DOI: 10.1007/S00109-012-0902-3 |
0.374 |
|
| 2012 |
Rossetti S, Hopp K, Sikkink RA, Sundsbak JL, Lee YK, Kubly V, Eckloff BW, Ward CJ, Winearls CG, Torres VE, Harris PC. Identification of gene mutations in autosomal dominant polycystic kidney disease through targeted resequencing. Journal of the American Society of Nephrology : Jasn. 23: 915-33. PMID 22383692 DOI: 10.1681/Asn.2011101032 |
0.71 |
|
| 2012 |
Chapman AB, Bost JE, Torres VE, Guay-Woodford L, Bae KT, Landsittel D, Li J, King BF, Martin D, Wetzel LH, Lockhart ME, Harris PC, Moxey-Mims M, Flessner M, Bennett WM, et al. Kidney volume and functional outcomes in autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 7: 479-86. PMID 22344503 DOI: 10.2215/Cjn.09500911 |
0.47 |
|
| 2012 |
Tebben PJ, Milliner DS, Horst RL, Harris PC, Singh RJ, Wu Y, Foreman JW, Chelminski PR, Kumar R. Hypercalcemia, hypercalciuria, and elevated calcitriol concentrations with autosomal dominant transmission due to CYP24A1 mutations: effects of ketoconazole therapy. The Journal of Clinical Endocrinology and Metabolism. 97: E423-7. PMID 22337913 DOI: 10.1210/Jc.2011-1935 |
0.373 |
|
| 2012 |
Torres VE, Harris PC. Polycystic kidney disease in 2011: Connecting the dots toward a polycystic kidney disease therapy. Nature Reviews. Nephrology. 8: 66-8. PMID 22158473 DOI: 10.1038/Nrneph.2011.196 |
0.445 |
|
| 2012 |
Syro LV, Sundsbak JL, Scheithauer BW, Toledo RA, Camargo M, Heyer CM, Sekiya T, Uribe H, Escobar JI, Vasquez M, Rotondo F, Toledo SP, Kovacs K, Horvath E, Babovic-Vuksanovic D, ... Harris PC, et al. Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation. Pituitary. 15: 342-9. PMID 21744088 DOI: 10.1007/S11102-011-0325-0 |
0.429 |
|
| 2011 |
Lim J, Gattone VH, Sinders R, Miller CA, Liang Y, Harris P, Watkins JB, Henshel DS. Acceleration of the meckel syndrome by near-infrared light therapy. Nephron Extra. 1: 224-34. PMID 22470396 DOI: 10.1159/000332046 |
0.337 |
|
| 2011 |
Thatava T, Armstrong AS, De Lamo JG, Edukulla R, Khan YK, Sakuma T, Ohmine S, Sundsbak JL, Harris PC, Kudva YC, Ikeda Y. Successful disease-specific induced pluripotent stem cell generation from patients with kidney transplantation. Stem Cell Research & Therapy. 2: 48. PMID 22142803 DOI: 10.1186/Scrt89 |
0.44 |
|
| 2011 |
Bakeberg JL, Tammachote R, Woollard JR, Hogan MC, Tuan HF, Li M, van Deursen JM, Wu Y, Huang BQ, Torres VE, Harris PC, Ward CJ. Epitope-tagged Pkhd1 tracks the processing, secretion, and localization of fibrocystin. Journal of the American Society of Nephrology : Jasn. 22: 2266-77. PMID 22021705 DOI: 10.1681/Asn.2010111173 |
0.408 |
|
| 2011 |
Irazabal MV, Huston J, Kubly V, Rossetti S, Sundsbak JL, Hogan MC, Harris PC, Brown RD, Torres VE. Extended follow-up of unruptured intracranial aneurysms detected by presymptomatic screening in patients with autosomal dominant polycystic kidney disease. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 1274-85. PMID 21551026 DOI: 10.2215/Cjn.09731110 |
0.371 |
|
| 2011 |
Hopp K, Heyer CM, Hommerding CJ, Henke SA, Sundsbak JL, Patel S, Patel P, Consugar MB, Czarnecki PG, Gliem TJ, Torres VE, Rossetti S, Harris PC. B9D1 is revealed as a novel Meckel syndrome (MKS) gene by targeted exon-enriched next-generation sequencing and deletion analysis. Human Molecular Genetics. 20: 2524-34. PMID 21493627 DOI: 10.1093/Hmg/Ddr151 |
0.702 |
|
| 2011 |
Hartley JL, O'Callaghan C, Rossetti S, Consugar M, Ward CJ, Kelly DA, Harris PC. Investigation of primary cilia in the pathogenesis of biliary atresia. Journal of Pediatric Gastroenterology and Nutrition. 52: 485-8. PMID 21407107 DOI: 10.1097/Mpg.0B013E318200Eb6F |
0.421 |
|
| 2011 |
Ward CJ, Wu Y, Johnson RA, Woollard JR, Bergstralh EJ, Cicek MS, Bakeberg J, Rossetti S, Heyer CM, Petersen GM, Lindor NM, Thibodeau SN, Harris PC, Torres VE, Hogan MC, et al. Germline PKHD1 mutations are protective against colorectal cancer. Human Genetics. 129: 345-9. PMID 21274727 DOI: 10.1007/S00439-011-0950-8 |
0.379 |
|
| 2011 |
Mohney BG, Pulido JS, Lindor NM, Hogan MC, Consugar MB, Peters J, Pankratz VS, Nasr SH, Smith SJ, Gloor J, Kubly V, Spencer D, Nielson R, Puffenberger EG, Strauss KA, ... ... Harris PC, et al. A novel mutation of LAMB2 in a multigenerational mennonite family reveals a new phenotypic variant of Pierson syndrome. Ophthalmology. 118: 1137-44. PMID 21236492 DOI: 10.1016/J.Ophtha.2010.10.009 |
0.396 |
|
| 2011 |
Mason SB, Lai X, Ringham HN, Bacallao RL, Harris PC, Witzmann FA, Gattone VH. Differential expression of renal proteins in a rodent model of Meckel syndrome. Nephron. Experimental Nephrology. 117: e31-8. PMID 20693816 DOI: 10.1159/000319722 |
0.415 |
|
| 2010 |
Mason SB, Liang Y, Sinders RM, Miller CA, Eggleston-Gulyas T, Crisler-Roberts R, Harris PC, Gattone VH. Disease stage characterization of hepatorenal fibrocystic pathology in the PCK rat model of ARPKD. Anatomical Record (Hoboken, N.J. : 2007). 293: 1279-88. PMID 20665806 DOI: 10.1002/Ar.21166 |
0.395 |
|
| 2010 |
Canaud G, Knebelmann B, Harris PC, Vrtovsnik F, Correas JM, Pallet N, Heyer CM, Letavernier E, Bienaimé F, Thervet E, Martinez F, Terzi F, Legendre C. Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level? American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 10: 1701-6. PMID 20642692 DOI: 10.1111/J.1600-6143.2010.03152.X |
0.471 |
|
| 2010 |
Liu M, Shi S, Senthilnathan S, Yu J, Wu E, Bergmann C, Zerres K, Bogdanova N, Coto E, Deltas C, Pierides A, Demetriou K, Devuyst O, Gitomer B, Laakso M, ... ... Harris PC, et al. Genetic variation of DKK3 may modify renal disease severity in ADPKD. Journal of the American Society of Nephrology : Jasn. 21: 1510-20. PMID 20616171 DOI: 10.1681/Asn.2010030237 |
0.465 |
|
| 2010 |
Vujic M, Heyer CM, Ars E, Hopp K, Markoff A, Orndal C, Rudenhed B, Nasr SH, Torres VE, Torra R, Bogdanova N, Harris PC. Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD. Journal of the American Society of Nephrology : Jasn. 21: 1097-102. PMID 20558538 DOI: 10.1681/Asn.2009101070 |
0.752 |
|
| 2010 |
Harris PC. What is the role of somatic mutation in autosomal dominant polycystic kidney disease? Journal of the American Society of Nephrology : Jasn. 21: 1073-6. PMID 20488953 DOI: 10.1681/Asn.2010030328 |
0.524 |
|
| 2010 |
Hogan MC, Masyuk TV, Page LJ, Kubly VJ, Bergstralh EJ, Li X, Kim B, King BF, Glockner J, Holmes DR, Rossetti S, Harris PC, LaRusso NF, Torres VE. Randomized clinical trial of long-acting somatostatin for autosomal dominant polycystic kidney and liver disease. Journal of the American Society of Nephrology : Jasn. 21: 1052-61. PMID 20431041 DOI: 10.1681/Asn.2009121291 |
0.366 |
|
| 2010 |
Harris PC, Rossetti S. Determinants of renal disease variability in ADPKD. Advances in Chronic Kidney Disease. 17: 131-9. PMID 20219616 DOI: 10.1053/J.Ackd.2009.12.004 |
0.521 |
|
| 2010 |
Harris PC, Rossetti S. Molecular diagnostics for autosomal dominant polycystic kidney disease. Nature Reviews. Nephrology. 6: 197-206. PMID 20177400 DOI: 10.1038/Nrneph.2010.18 |
0.466 |
|
| 2010 |
Kurbegovic A, Côté O, Couillard M, Ward CJ, Harris PC, Trudel M. Pkd1 transgenic mice: adult model of polycystic kidney disease with extrarenal and renal phenotypes. Human Molecular Genetics. 19: 1174-89. PMID 20053665 DOI: 10.1093/Hmg/Ddp588 |
0.424 |
|
| 2010 |
Mangolini A, Bogo M, Durante C, Borgatti M, Gambari R, Harris PC, Rizzuto R, Pinton P, Aguiari G, del Senno L. NF-kappaB activation is required for apoptosis in fibrocystin/polyductin-depleted kidney epithelial cells. Apoptosis : An International Journal On Programmed Cell Death. 15: 94-104. PMID 19943112 DOI: 10.1007/S10495-009-0426-7 |
0.328 |
|
| 2010 |
Wang X, Ward CJ, Harris PC, Torres VE. Cyclic nucleotide signaling in polycystic kidney disease. Kidney International. 77: 129-40. PMID 19924104 DOI: 10.1038/Ki.2009.438 |
0.456 |
|
| 2010 |
Canaud G, Knebelmann B, Harris PC, Vrtovsnik F, Correas JM, Pallet N, Heyer CM, Letavernier E, Bienaimé F, Thervet E, Martinez F, Terzi F, Legendre C. Therapeutic mTOR inhibition in autosomal dominant polycystic kidney disease: What is the appropriate serum level? American Journal of Transplantation. 10: 1710-1715. DOI: 10.1111/j.1600-6143.2010.03152.x |
0.326 |
|
| 2010 |
Torres VE, Harris PC. Autosomal Dominant Polycystic Kidney Disease Comprehensive Clinical Nephrology. 529-542. DOI: 10.1016/B978-0-323-05876-6.00044-7 |
0.41 |
|
| 2009 |
Tammachote R, Hommerding CJ, Sinders RM, Miller CA, Czarnecki PG, Leightner AC, Salisbury JL, Ward CJ, Torres VE, Gattone VH, Harris PC. Ciliary and centrosomal defects associated with mutation and depletion of the Meckel syndrome genes MKS1 and MKS3. Human Molecular Genetics. 18: 3311-23. PMID 19515853 DOI: 10.1093/Hmg/Ddp272 |
0.802 |
|
| 2009 |
Torres VE, Harris PC. Autosomal dominant polycystic kidney disease: the last 3 years. Kidney International. 76: 149-68. PMID 19455193 DOI: 10.1038/Ki.2009.128 |
0.459 |
|
| 2009 |
Harris PC. 2008 Homer W. Smith Award: insights into the pathogenesis of polycystic kidney disease from gene discovery. Journal of the American Society of Nephrology : Jasn. 20: 1188-98. PMID 19423684 DOI: 10.1681/Asn.2009010014 |
0.518 |
|
| 2009 |
Streets AJ, Wagner BE, Harris PC, Ward CJ, Ong AC. Homophilic and heterophilic polycystin 1 interactions regulate E-cadherin recruitment and junction assembly in MDCK cells. Journal of Cell Science. 122: 1410-7. PMID 19351715 DOI: 10.1242/Jcs.045021 |
0.387 |
|
| 2009 |
Aguiari G, Varani K, Bogo M, Mangolini A, Vincenzi F, Durante C, Gessi S, Sacchetto V, Catizone L, Harris P, Rizzuto R, Borea PA, Senno Ld. Deficiency of polycystic kidney disease-1 gene (PKD1) expression increases A3 adenosine receptors in human renal cells: Implications for cAMP-dependent signalling and proliferation of PKD1-mutated cystic cells Biochimica Et Biophysica Acta. 1792: 531-540. PMID 19285554 DOI: 10.1016/J.Bbadis.2009.03.001 |
0.414 |
|
| 2009 |
Xu C, Shmukler BE, Nishimura K, Kaczmarek E, Rossetti S, Harris PC, Wandinger-Ness A, Bacallao RL, Alper SL. Attenuated, flow-induced ATP release contributes to absence of flow-sensitive, purinergic Cai2+ signaling in human ADPKD cyst epithelial cells. American Journal of Physiology. Renal Physiology. 296: F1464-76. PMID 19244404 DOI: 10.1152/Ajprenal.90542.2008 |
0.309 |
|
| 2009 |
Rossetti S, Kubly VJ, Consugar MB, Hopp K, Roy S, Horsley SW, Chauveau D, Rees L, Barratt TM, van't Hoff WG, Niaudet P, Niaudet WP, Torres VE, Harris PC. Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease. Kidney International. 75: 848-55. PMID 19165178 DOI: 10.1038/Ki.2008.686 |
0.745 |
|
| 2009 |
Hogan MC, Manganelli L, Woollard JR, Masyuk AI, Masyuk TV, Tammachote R, Huang BQ, Leontovich AA, Beito TG, Madden BJ, Charlesworth MC, Torres VE, LaRusso NF, Harris PC, Ward CJ. Characterization of PKD protein-positive exosome-like vesicles. Journal of the American Society of Nephrology : Jasn. 20: 278-88. PMID 19158352 DOI: 10.1681/Asn.2008060564 |
0.4 |
|
| 2009 |
Harris PC, Torres VE. Polycystic kidney disease. Annual Review of Medicine. 60: 321-37. PMID 18947299 DOI: 10.1146/Annurev.Med.60.101707.125712 |
0.534 |
|
| 2009 |
Wang X, Harris PC, Somlo S, Batlle D, Torres VE. Effect of calcium-sensing receptor activation in models of autosomal recessive or dominant polycystic kidney disease. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 24: 526-34. PMID 18826972 DOI: 10.1093/Ndt/Gfn527 |
0.381 |
|
| 2009 |
Harris PC, Czarnecki PG. Ciliopathies Medizinische Genetik. 21: 14-20. DOI: 10.1007/s11825-009-0144-0 |
0.365 |
|
| 2008 |
Consugar MB, Wong WC, Lundquist PA, Rossetti S, Kubly VJ, Walker DL, Rangel LJ, Aspinwall R, Niaudet WP, Ozen S, David A, Velinov M, Bergstralh EJ, Bae KT, Chapman AB, ... ... Harris PC, et al. Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1/TSC2 contiguous gene syndrome. Kidney International. 74: 1468-79. PMID 18818683 DOI: 10.1038/Ki.2008.485 |
0.479 |
|
| 2008 |
Aitman TJ, Critser JK, Cuppen E, Dominiczak A, Fernandez-Suarez XM, Flint J, Gauguier D, Geurts AM, Gould M, Harris PC, Holmdahl R, Hubner N, Izsvák Z, Jacob HJ, Kuramoto T, et al. Progress and prospects in rat genetics: a community view. Nature Genetics. 40: 516-22. PMID 18443588 DOI: 10.1038/Ng.147 |
0.35 |
|
| 2008 |
Aguiari G, Trimi V, Bogo M, Mangolini A, Szabadkai G, Pinton P, Witzgall R, Harris PC, Borea PA, Rizzuto R, del Senno L. Novel role for polycystin-1 in modulating cell proliferation through calcium oscillations in kidney cells. Cell Proliferation. 41: 554-73. PMID 18422703 DOI: 10.1111/J.1365-2184.2008.00529.X |
0.332 |
|
| 2008 |
Dedoussis GVZ, Luo Y, Starremans P, Rossetti S, Ramos AJ, Cantiello HF, Katsareli E, Ziroyannis P, Lamnissou K, Harris PC, Zhou J. Co-inheritance of a PKD1 mutation and homozygous PKD2 variant: A potential modifier in autosomal dominant polycystic kidney disease European Journal of Clinical Investigation. 38: 180-190. PMID 18257781 DOI: 10.1111/J.1365-2362.2007.01913.X |
0.48 |
|
| 2008 |
Harris PC, Rossetti S. Molecular diagnostics of ADPKD coming of age. Clinical Journal of the American Society of Nephrology : Cjasn. 3: 1-2. PMID 18178778 DOI: 10.2215/Cjn.05061107 |
0.403 |
|
| 2008 |
Wang X, Wu Y, Ward CJ, Harris PC, Torres VE. Vasopressin directly regulates cyst growth in polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 19: 102-8. PMID 18032793 DOI: 10.1681/Asn.2007060688 |
0.42 |
|
| 2008 |
Grantham JJ, Cook LT, Torres VE, Bost JE, Chapman AB, Harris PC, Guay-Woodford LM, Bae KT. Determinants of renal volume in autosomal-dominant polycystic kidney disease. Kidney International. 73: 108-16. PMID 17960141 DOI: 10.1038/Sj.Ki.5002624 |
0.386 |
|
| 2008 |
Harris PC, Torres VE. Autosomal recessive polycystic kidney disease Molecular and Genetic Basis of Renal Disease. 119-130. DOI: 10.1016/B978-1-4160-0252-9.50011-2 |
0.418 |
|
| 2007 |
Torres VE, Rossetti S, Harris PC. Update on autosomal dominant polycystic kidney disease Minerva Medica. 98: 669-691. PMID 18299682 |
0.412 |
|
| 2007 |
Harris PC. Genetic complexity in Joubert syndrome and related disorders Kidney International. 72: 1421-1423. PMID 18046420 DOI: 10.1038/Sj.Ki.5002577 |
0.312 |
|
| 2007 |
Rossetti S, Consugar MB, Chapman AB, Torres VE, Guay-Woodford LM, Grantham JJ, Bennett WM, Meyers CM, Walker DL, Bae K, Zhang QJ, Thompson PA, Miller JP, Harris PC. Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 18: 2143-60. PMID 17582161 DOI: 10.1681/Asn.2006121387 |
0.462 |
|
| 2007 |
Woollard JR, Punyashtiti R, Richardson S, Masyuk TV, Whelan S, Huang BQ, Lager DJ, vanDeursen J, Torres VE, Gattone VH, LaRusso NF, Harris PC, Ward CJ. A mouse model of autosomal recessive polycystic kidney disease with biliary duct and proximal tubule dilatation. Kidney International. 72: 328-36. PMID 17519956 DOI: 10.1038/Sj.Ki.5002294 |
0.463 |
|
| 2007 |
Monico CG, Rossetti S, Schwanz HA, Olson JB, Lundquist PA, Dawson DB, Harris PC, Milliner DS. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis. Journal of the American Society of Nephrology : Jasn. 18: 1905-14. PMID 17460142 DOI: 10.1681/Asn.2006111230 |
0.388 |
|
| 2007 |
Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet (London, England). 369: 1287-301. PMID 17434405 DOI: 10.1016/S0140-6736(07)60601-1 |
0.459 |
|
| 2007 |
Rossetti S, Harris PC. Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 18: 1374-80. PMID 17429049 DOI: 10.1681/Asn.2007010125 |
0.514 |
|
| 2007 |
Parker E, Newby LJ, Sharpe CC, Rossetti S, Streets AJ, Harris PC, O'Hare MJ, Ong AC. Hyperproliferation of PKD1 cystic cells is induced by insulin-like growth factor-1 activation of the Ras/Raf signalling system. Kidney International. 72: 157-65. PMID 17396115 DOI: 10.1038/Sj.Ki.5002229 |
0.4 |
|
| 2007 |
Masyuk TV, Masyuk AI, Torres VE, Harris PC, Larusso NF. Octreotide inhibits hepatic cystogenesis in a rodent model of polycystic liver disease by reducing cholangiocyte adenosine 3',5'-cyclic monophosphate. Gastroenterology. 132: 1104-16. PMID 17383431 DOI: 10.1053/J.Gastro.2006.12.039 |
0.372 |
|
| 2007 |
Consugar MB, Kubly VJ, Lager DJ, Hommerding CJ, Wong WC, Bakker E, Gattone VH, Torres VE, Breuning MH, Harris PC. Molecular diagnostics of Meckel-Gruber syndrome highlights phenotypic differences between MKS1 and MKS3. Human Genetics. 121: 591-9. PMID 17377820 DOI: 10.1007/S00439-007-0341-3 |
0.45 |
|
| 2007 |
Torres VE, Harris PC. Polycystic kidney disease: Genes, proteins, animal models, disease mechanisms and therapeutic opportunities Journal of Internal Medicine. 261: 17-31. PMID 17222165 DOI: 10.1111/J.1365-2796.2006.01743.X |
0.404 |
|
| 2007 |
Xu C, Rossetti S, Jiang L, Harris PC, Brown-Glaberman U, Wandinger-Ness A, Bacallao R, Alper SL. Human ADPKD primary cyst epithelial cells with a novel, single codon deletion in the PKD1 gene exhibit defective ciliary polycystin localization and loss of flow-induced Ca2+ signaling. American Journal of Physiology. Renal Physiology. 292: F930-45. PMID 17090781 DOI: 10.1152/Ajprenal.00285.2006 |
0.463 |
|
| 2006 |
Xu N, Glockner JF, Rossetti S, Babovich-Vuksanovic D, Harris PC, Torres VE. Autosomal dominant polycystic kidney disease coexisting with cystic fibrosis. Journal of Nephrology. 19: 529-34. PMID 17048214 |
0.371 |
|
| 2006 |
Harris PC, Bae KT, Rossetti S, Torres VE, Grantham JJ, Chapman AB, Guay-Woodford LM, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Consugar M, Klahr S, Bennett WM, Meyers CM, et al. Cyst number but not the rate of cystic growth is associated with the mutated gene in autosomal dominant polycystic kidney disease. Journal of the American Society of Nephrology : Jasn. 17: 3013-9. PMID 17035604 DOI: 10.1681/Asn.2006080835 |
0.518 |
|
| 2006 |
Hiesberger T, Gourley E, Erickson A, Koulen P, Ward CJ, Masyuk TV, Larusso NF, Harris PC, Igarashi P. Proteolytic cleavage and nuclear translocation of fibrocystin is regulated by intracellular Ca2+ and activation of protein kinase C. The Journal of Biological Chemistry. 281: 34357-64. PMID 16956880 DOI: 10.1074/Jbc.M606740200 |
0.306 |
|
| 2006 |
Torres VE, Harris PC. Mechanisms of Disease: autosomal dominant and recessive polycystic kidney diseases. Nature Clinical Practice. Nephrology. 2: 40-55; quiz 55. PMID 16932388 DOI: 10.1038/Ncpneph0070 |
0.548 |
|
| 2006 |
Sutton KA, Jungnickel MK, Ward CJ, Harris PC, Florman HM. Functional characterization of PKDREJ, a male germ cell-restricted polycystin. Journal of Cellular Physiology. 209: 493-500. PMID 16883570 DOI: 10.1002/Jcp.20755 |
0.301 |
|
| 2006 |
Harris PC, Torres VE. Understanding pathogenic mechanisms in polycystic kidney disease provides clues for therapy. Current Opinion in Nephrology and Hypertension. 15: 456-63. PMID 16775462 DOI: 10.1097/01.Mnh.0000232888.65895.E7 |
0.483 |
|
| 2006 |
Grantham JJ, Torres VE, Chapman AB, Guay-Woodford LM, Bae KT, King BF, Wetzel LH, Baumgarten DA, Kenney PJ, Harris PC, Klahr S, Bennett WM, Hirschman GN, Meyers CM, Zhang X, et al. Volume progression in polycystic kidney disease. The New England Journal of Medicine. 354: 2122-30. PMID 16707749 DOI: 10.1056/Nejmoa054341 |
0.504 |
|
| 2006 |
Nauli SM, Rossetti S, Kolb RJ, Alenghat FJ, Consugar MB, Harris PC, Ingber DE, Loghman-Adham M, Zhou J. Loss of polycystin-1 in human cyst-lining epithelia leads to ciliary dysfunction. Journal of the American Society of Nephrology : Jasn. 17: 1015-25. PMID 16565258 DOI: 10.1681/Asn.2005080830 |
0.424 |
|
| 2006 |
Woerner AC, Au KS, Williams AT, Harris PC, Northrup H. Tuberous sclerosis complex and polycystic kidney disease together: an exception to the contiguous gene syndrome. Genetics in Medicine : Official Journal of the American College of Medical Genetics. 8: 197-8. PMID 16540757 DOI: 10.1097/01.Gim.0000204466.34876.D5 |
0.427 |
|
| 2006 |
Adeva M, El-Youssef M, Rossetti S, Kamath PS, Kubly V, Consugar MB, Milliner DM, King BF, Torres VE, Harris PC. Clinical and molecular characterization defines a broadened spectrum of autosomal recessive polycystic kidney disease (ARPKD). Medicine. 85: 1-21. PMID 16523049 DOI: 10.1097/01.Md.0000200165.90373.9A |
0.504 |
|
| 2006 |
Smith UM, Consugar M, Tee LJ, McKee BM, Maina EN, Whelan S, Morgan NV, Goranson E, Gissen P, Lilliquist S, Aligianis IA, Ward CJ, Pasha S, Punyashthiti R, Malik Sharif S, ... ... Harris PC, et al. The transmembrane protein meckelin (MKS3) is mutated in Meckel-Gruber syndrome and the wpk rat. Nature Genetics. 38: 191-6. PMID 16415887 DOI: 10.1038/Ng1713 |
0.461 |
|
| 2005 |
Kip SN, Hunter LW, Ren Q, Harris PC, Somlo S, Torres VE, Sieck GC, Qian Q. [Ca2+]i reduction increases cellular proliferation and apoptosis in vascular smooth muscle cells: relevance to the ADPKD phenotype. Circulation Research. 96: 873-80. PMID 15790956 DOI: 10.1161/01.Res.0000163278.68142.8A |
0.314 |
|
| 2005 |
Ong AC, Harris PC. Molecular pathogenesis of ADPKD: the polycystin complex gets complex. Kidney International. 67: 1234-47. PMID 15780076 DOI: 10.1111/J.1523-1755.2005.00201.X |
0.515 |
|
| 2005 |
Wang X, Gattone V, Harris PC, Torres VE. Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. Journal of the American Society of Nephrology : Jasn. 16: 846-51. PMID 15728778 DOI: 10.1681/Asn.2004121090 |
0.434 |
|
| 2005 |
Consugar MB, Anderson SA, Rossetti S, Pankratz VS, Ward CJ, Torra R, Coto E, El-Youssef M, Kantarci S, Utsch B, Hildebrandt F, Sweeney WE, Avner ED, Torres VE, Cunningham JM, ... Harris PC, et al. Haplotype analysis improves molecular diagnostics of autosomal recessive polycystic kidney disease. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 45: 77-87. PMID 15696446 DOI: 10.1053/J.Ajkd.2004.09.009 |
0.499 |
|
| 2005 |
Harris PC. The Genetics of Renal Disease. American Journal of Human Genetics. 76: 368-369. DOI: 10.1086/427891 |
0.504 |
|
| 2004 |
Masyuk TV, Huang BQ, Masyuk AI, Ritman EL, Torres VE, Wang X, Harris PC, Larusso NF. Biliary dysgenesis in the PCK rat, an orthologous model of autosomal recessive polycystic kidney disease. The American Journal of Pathology. 165: 1719-30. PMID 15509540 DOI: 10.1016/S0002-9440(10)63427-X |
0.42 |
|
| 2004 |
Ireland J, Rossetti S, Haugen E, Ireland J, Michels V, Harris PC. Mitochondrial causes of renal insufficiency and hearing loss Kidney International. 65: 2444-2445. PMID 15149362 DOI: 10.1111/J.1523-1755.2004.665_4.X |
0.439 |
|
| 2004 |
Bergmann C, Senderek J, Küpper F, Schneider F, Dornia C, Windelen E, Eggermann T, Rudnik-Schöneborn S, Kirfel J, Furu L, Onuchic LF, Rossetti S, Harris PC, Somlo S, Guay-Woodford L, et al. PKHD1 mutations in autosomal recessive polycystic kidney disease (ARPKD). Human Mutation. 23: 453-63. PMID 15108277 DOI: 10.1002/Humu.20029 |
0.457 |
|
| 2004 |
Gibbs GF, Huston J, Qian Q, Kubly V, Harris PC, Brown RD, Torres VE. Follow-up of intracranial aneurysms in autosomal-dominant polycystic kidney disease. Kidney International. 65: 1621-7. PMID 15086900 DOI: 10.1111/J.1523-1755.2004.00572.X |
0.372 |
|
| 2004 |
Gattone VH, Tourkow BA, Trambaugh CM, Yu AC, Whelan S, Phillips CL, Harris PC, Peterson RG. Development of multiorgan pathology in the wpk rat model of polycystic kidney disease. The Anatomical Record. Part a, Discoveries in Molecular, Cellular, and Evolutionary Biology. 277: 384-95. PMID 15052665 DOI: 10.1002/Ar.A.20022 |
0.432 |
|
| 2004 |
Aguiari G, Banzi M, Gessi S, Cai Y, Zeggio E, Manzati E, Piva R, Lambertini E, Ferrari L, Peters DJ, Lanza F, Harris PC, Borea PA, Somlo S, Del Senno L. Deficiency of polycystin-2 reduces Ca2+ channel activity and cell proliferation in ADPKD lymphoblastoid cells. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 18: 884-6. PMID 15001556 DOI: 10.1096/Fj.03-0687Fje |
0.398 |
|
| 2004 |
Torres VE, Wang X, Qian Q, Somlo S, Harris PC, Gattone VH. Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nature Medicine. 10: 363-4. PMID 14991049 DOI: 10.1038/Nm1004 |
0.489 |
|
| 2004 |
Harris PC, Rossetti S. Molecular genetics of autosomal recessive polycystic kidney disease. Molecular Genetics and Metabolism. 81: 75-85. PMID 14741187 DOI: 10.1016/J.Ymgme.2003.10.010 |
0.564 |
|
| 2004 |
Roitbak T, Ward CJ, Harris PC, Bacallao R, Ness SA, Wandinger-Ness A. A polycystin-1 multiprotein complex is disrupted in polycystic kidney disease cells. Molecular Biology of the Cell. 15: 1334-46. PMID 14718571 DOI: 10.1091/Mbc.E03-05-0296 |
0.413 |
|
| 2004 |
Rossetti S, Torra R, Coto E, Consugar M, Kubly V, Málaga S, Navarro M, El-Youssef M, Torres VE, Harris PC. A complete mutation screen of PKHD1 in autosomal-recessive polycystic kidney disease (ARPKD) pedigrees. Kidney International. 64: 391-403. PMID 12846734 DOI: 10.1046/J.1523-1755.2003.00111.X |
0.506 |
|
| 2003 |
Masyuk TV, Huang BQ, Ward CJ, Masyuk AI, Yuan D, Splinter PL, Punyashthiti R, Ritman EL, Torres VE, Harris PC, LaRusso NF. Defects in cholangiocyte fibrocystin expression and ciliary structure in the PCK rat. Gastroenterology. 125: 1303-10. PMID 14598246 DOI: 10.1016/J.Gastro.2003.09.001 |
0.45 |
|
| 2003 |
Torres VE, Sweeney WE, Wang X, Qian Q, Harris PC, Frost P, Avner ED. EGF receptor tyrosine kinase inhibition attenuates the development of PKD in Han:SPRD rats. Kidney International. 64: 1573-9. PMID 14531789 DOI: 10.1046/J.1523-1755.2003.00256.X |
0.302 |
|
| 2003 |
Gattone VH, Wang X, Harris PC, Torres VE. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nature Medicine. 9: 1323-6. PMID 14502283 DOI: 10.1038/Nm935 |
0.482 |
|
| 2003 |
Qian Q, Li M, Cai Y, Ward CJ, Somlo S, Harris PC, Torres VE. Analysis of the polycystins in aortic vascular smooth muscle cells. Journal of the American Society of Nephrology : Jasn. 14: 2280-7. PMID 12937304 DOI: 10.1097/01.Asn.0000080185.38113.A3 |
0.341 |
|
| 2003 |
Ward CJ, Yuan D, Masyuk TV, Wang X, Punyashthiti R, Whelan S, Bacallao R, Torra R, LaRusso NF, Torres VE, Harris PC. Cellular and subcellular localization of the ARPKD protein; fibrocystin is expressed on primary cilia. Human Molecular Genetics. 12: 2703-10. PMID 12925574 DOI: 10.1093/Hmg/Ddg274 |
0.392 |
|
| 2003 |
Qian Q, Hunter LW, Li M, Marin-Padilla M, Prakash YS, Somlo S, Harris PC, Torres VE, Sieck GC. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Human Molecular Genetics. 12: 1875-80. PMID 12874107 DOI: 10.1093/Hmg/Ddg190 |
0.353 |
|
| 2003 |
Rossetti S, Chauveau D, Kubly V, Slezak JM, Saggar-Malik AK, Pei Y, Ong AC, Stewart F, Watson ML, Bergstralh EJ, Winearls CG, Torres VE, Harris PC. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet (London, England). 361: 2196-201. PMID 12842373 DOI: 10.1016/S0140-6736(03)13773-7 |
0.472 |
|
| 2003 |
Hogan MC, Griffin MD, Rossetti S, Torres VE, Ward CJ, Harris PC. PKHDL1, a homolog of the autosomal recessive polycystic kidney disease gene, encodes a receptor with inducible T lymphocyte expression Human Molecular Genetics. 12: 685-698. PMID 12620974 DOI: 10.1093/Hmg/Ddg068 |
0.377 |
|
| 2003 |
Walker D, Consugar M, Slezak J, Rossetti S, Torres VE, Winearls CG, Harris PC. The ENOS polymorphism is not associated with severity of renal disease in polycystic kidney disease 1 American Journal of Kidney Diseases. 41: 90-94. PMID 12500225 DOI: 10.1053/Ajkd.2003.50027 |
0.495 |
|
| 2002 |
Muto S, Aiba A, Saito Y, Nakao K, Nakamura K, Tomita K, Kitamura T, Kurabayashi M, Nagai R, Higashihara E, Harris PC, Katsuki M, Horie S. Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant Human Molecular Genetics. 11: 1731-1742. PMID 12095915 DOI: 10.1093/Hmg/11.15.1731 |
0.45 |
|
| 2002 |
Harris PC. Molecular basis of polycystic kidney disease: PKD1, PKD2 and PKHD1 Current Opinion in Nephrology and Hypertension. 11: 309-314. PMID 11981261 DOI: 10.1097/00041552-200205000-00007 |
0.521 |
|
| 2002 |
Rossetti S, Chauveau D, Walker D, Saggar-Malik A, Winearls CG, Torres VE, Harris PC. A complete mutation screen of the ADPKD genes by DHPLC. Kidney International. 61: 1588-99. PMID 11967008 DOI: 10.1046/J.1523-1755.2002.00326.X |
0.443 |
|
| 2002 |
Rossetti S, Burton S, Strmecki L, Pond GR, San Millán JL, Zerres K, Barratt TM, Ozen S, Torres VE, Bergstralh EJ, Winearls CG, Harris PC. The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. Journal of the American Society of Nephrology : Jasn. 13: 1230-7. PMID 11961010 DOI: 10.1097/01.Asn.0000013300.11876.37 |
0.545 |
|
| 2002 |
Ward CJ, Hogan MC, Rossetti S, Walker D, Sneddon T, Wang X, Kubly V, Cunningham JM, Bacallao R, Ishibashi M, Milliner DS, Torres VE, Harris PC. The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nature Genetics. 30: 259-69. PMID 11919560 DOI: 10.1038/Ng833 |
0.51 |
|
| 2002 |
Newby LJ, Streets AJ, Zhao Y, Harris PC, Ward CJ, Ong ACM. Identification, characterization, and localization of a novel kidney polycystin-1-polycystin-2 complex Journal of Biological Chemistry. 277: 20763-20773. PMID 11901144 DOI: 10.1074/Jbc.M107788200 |
0.405 |
|
| 2002 |
Delmas P, Nomura H, Li X, Lakkis M, Luo Y, Segal Y, Fernández-Fernández JM, Harris P, Frischauf AM, Brown DA, Zhou J. Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2. The Journal of Biological Chemistry. 277: 11276-83. PMID 11786542 DOI: 10.1074/Jbc.M110483200 |
0.326 |
|
| 2001 |
Qian Q, Harris PC, Torres VE. Treatment prospects for autosomal-dominant polycystic kidney disease Kidney International. 59: 2005-2022. PMID 11380803 DOI: 10.1046/J.1523-1755.2001.00716.X |
0.443 |
|
| 2001 |
Kleymenova E, Ibraghimov-Beskrovnaya O, Kugoh H, Everitt J, Xu H, Kiguchi K, Landes G, Harris PC, Walker C. Tuberin-Dependent Membrane Localization of Polycystin-1: A Functional Link between Polycystic Kidney Disease and the TSC2 Tumor Suppressor Gene Molecular Cell. 7: 823-832. PMID 11336705 DOI: 10.1016/S1097-2765(01)00226-X |
0.471 |
|
| 2001 |
González-Perrett S, Kim K, Ibarra C, Damiano AE, Zotta E, Batelli M, Harris PC, Reisin IL, Arnaout MA, Cantiello HF. Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proceedings of the National Academy of Sciences of the United States of America. 98: 1182-7. PMID 11252306 DOI: 10.1073/Pnas.98.3.1182 |
0.317 |
|
| 2001 |
Rossetti S, Strmecki L, Gamble V, Burton S, Sneddon V, Peral B, Roy S, Bakkaloglu A, Komel R, Winearls CG, Harris PC. Mutation Analysis of the Entire PKD1 Gene: Genetic and Diagnostic Implications American Journal of Human Genetics. 68: 46-63. PMID 11115377 DOI: 10.1086/316939 |
0.423 |
|
| 2000 |
Koptides M, Mean R, Demetriou K, Constantinides R, Pierides A, Harris PC, Deltas CC. Screening of the PKD1 duplicated region reveals multiple single nucleotide polymorphisms and a de novo mutation in Hellenic polycystic kidney disease families Human Mutation. 16: 176. PMID 10923040 DOI: 10.1002/1098-1004(200008)16:2<176::Aid-Humu11>3.0.Co;2-H |
0.486 |
|
| 1999 |
Ong AC, Harris PC, Davies DR, Pritchard L, Rossetti S, Biddolph S, Vaux DJ, Migone N, Ward CJ. Polycystin-1 expression in PKD1, early-onset PKD1, and TSC2/PKD1 cystic tissue. Kidney International. 56: 1324-33. PMID 10504485 DOI: 10.1046/J.1523-1755.1999.00659.X |
0.444 |
|
| 1999 |
Harris PC. Autosomal dominant polycystic kidney disease: Clues to pathogenesis Human Molecular Genetics. 8: 1861-1866. PMID 10469838 DOI: 10.1093/Hmg/8.10.1861 |
0.525 |
|
| 1999 |
Torra R, Viribay M, Tellería D, Badenas C, Watson M, Harris P, Darnell A, Millán JLS. Seven novel mutations of the PKD2 gene in families with autosomal dominant polycystic kidney disease. Kidney International. 56: 28-33. PMID 10411676 DOI: 10.1046/J.1523-1755.1999.00534.X |
0.495 |
|
| 1999 |
Ong AC, Ward CJ, Butler RJ, Biddolph S, Bowker C, Torra R, Pei Y, Harris PC. Coordinate expression of the autosomal dominant polycystic kidney disease proteins, polycystin-2 and polycystin-1, in normal and cystic tissue. The American Journal of Pathology. 154: 1721-9. PMID 10362797 DOI: 10.1016/S0002-9440(10)65428-4 |
0.425 |
|
| 1999 |
Lu W, Fan X, Basora N, Babakhanlou H, Law T, Rifai N, Harris PC, Perez-Atayde AR, Rennke HG, Zhou J. Late onset of renal and hepatic cysts in Pkd1-targeted heterozygotes. Nature Genetics. 21: 160-1. PMID 9988265 DOI: 10.1038/5944 |
0.378 |
|
| 1999 |
Hughes J, Ward CJ, Aspinwall R, Butler R, Harris PC. Identification of a human homologue of the sea urchin receptor for egg jelly: A polycystic kidney disease-like protein Human Molecular Genetics. 8: 543-549. PMID 9949214 DOI: 10.1093/Hmg/8.3.543 |
0.349 |
|
| 1998 |
Torra R, Badenas C, Darnell A, Camacho JA, Aspinwall R, Harris PC, Estivill X. Facilitated diagnosis of the contiguous gene syndrome: tuberous sclerosis and polycystic kidneys by means of haplotype studies. American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation. 31: 1038-43. PMID 9631851 DOI: 10.1053/Ajkd.1998.V31.Pm9631851 |
0.489 |
|
| 1998 |
Torra R, Badenas C, Peral B, Darnell A, Serra E, Gamble V, Turco AE, Harris PC, Estivill X. Recurrence of the PKD1 nonsense mutation Q4041X in Spanish, Italian, and British families Human Mutation. 11: 117-120. PMID 9452060 DOI: 10.1002/Humu.1380110139 |
0.349 |
|
| 1997 |
Viribay M, Hayashi T, Tellería D, Mochizuki T, Reynolds DM, Alonso R, Lens XM, Moreno F, Harris PC, Somlo S, San Millán JL. Novel stop and frameshifting mutations in the autosomal dominant polycystic kidney disease 2 (PKD2) gene Human Genetics. 101: 229-234. PMID 9402976 DOI: 10.1007/S004390050621 |
0.457 |
|
| 1997 |
Griffin MD, Gamble V, Milliner DS, Gomez MR, Harris PC, Torres VE. Neonatal presentation of autosomal dominant polycystic kidney disease with a maternal history of tuberous sclerosis. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 12: 2284-8. PMID 9394312 DOI: 10.1093/Ndt/12.11.2284 |
0.513 |
|
| 1997 |
Sampson JR, Maheshwar MM, Aspinwall R, Thompson P, Cheadle JP, Ravine D, Roy S, Haan E, Bernstein J, Harris PC. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene American Journal of Human Genetics. 61: 843-851. PMID 9382094 DOI: 10.1086/514888 |
0.543 |
|
| 1997 |
Maheshwar MM, Cheadle JP, Jones AC, Myring J, Fryer AE, Harris PC, Sampson JR. The GAP-related domain of tuberin, the product of the TSC2 gene, is a target for missense mutations in tuberous sclerosis. Human Molecular Genetics. 6: 1991-6. PMID 9302281 DOI: 10.1093/hmg/6.11.1991 |
0.313 |
|
| 1997 |
Sandford R, Sgotto B, Aparicio S, Brenner S, Vaudin M, Wilson RK, Chissoe S, Pepin K, Bateman A, Chothia C, Hughes J, Harris P. Comparative analysis of the polycystic kidney disease 1 (PKD1) gene reveals an integral membrane glycoprotein with multiple evolutionary conserved domains Human Molecular Genetics. 6: 1483-1489. PMID 9285785 DOI: 10.1093/Hmg/6.9.1483 |
0.372 |
|
| 1997 |
Kobayashi T, Urakami S, Cheadle JP, Aspinwall R, Harris P, Sampson JR, Hino O. Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homolog. Mammalian Genome. 8: 554-558. PMID 9250859 DOI: 10.1007/S003359900502 |
0.354 |
|
| 1997 |
Peral B, Gamble V, Strong C, Ong ACM, Sloane-Stanley J, Zerres K, Winearls CG, Harris PC. Identification of Mutations in the Duplicated Region of the Polycystic Kidney Disease 1 Gene (PKD1) by a Novel Approach American Journal of Human Genetics. 60: 1399-1410. PMID 9199561 DOI: 10.1086/515467 |
0.429 |
|
| 1997 |
Harris PC, Watson ML. Autosomal dominant polycystic kidney disease: neoplasia in disguise? Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 12: 1089-90. PMID 9198029 DOI: 10.1093/Ndt/12.6.1089 |
0.496 |
|
| 1997 |
Ong ACM, Harris PC. Molecular basis of renal cyst formation - One hit two? Lancet. 349: 1039-1040. PMID 9107237 DOI: 10.1016/S0140-6736(05)62286-6 |
0.389 |
|
| 1997 |
Harris PC. Autosomal dominant polycystic kidney disease: A genetic perspective Nephrology. 3: 387-395. DOI: 10.1111/J.1440-1797.1997.Tb00261.X |
0.487 |
|
| 1996 |
Peral B, Ong ACM, San Millán JL, Gamble V, Rees L, Harris PC. A stable, nonsense mutation associated with a case of infantile onset polycystic kidney disease 1 (PKD1) Human Molecular Genetics. 5: 539-542. PMID 8845849 DOI: 10.1093/Hmg/5.4.539 |
0.539 |
|
| 1996 |
Harris PC. Identification of a gene for autosomal dominant polycystic kidney disease: Implications for understanding the pathogenesis and treatment of the disease Nephrology Dialysis Transplantation. 11: 258-262. PMID 8700362 DOI: 10.1093/Oxfordjournals.Ndt.A027250 |
0.472 |
|
| 1996 |
Olsson PG, Lohning C, Horsley S, Kearney L, Harris PC, Frischauf AM. The mouse homologue of the polycystic kidney disease gene (Pkd1) is a single-copy gene Genomics. 34: 233-235. PMID 8661056 DOI: 10.1006/Geno.1996.0273 |
0.367 |
|
| 1995 |
Harris PC, Ward CJ, Peral B, Hughes J. Autosomal dominant polycystic kidney disease: Molecular analysis Human Molecular Genetics. 4: 1745-1749. PMID 8541874 DOI: 10.1093/Hmg/4.Suppl_1.1745 |
0.441 |
|
| 1995 |
Hughes J, Ward CJ, Peral B, Aspinwall R, Clark K, San Millán JL, Gamble V, Harris PC. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nature Genetics. 10: 151-60. PMID 7663510 DOI: 10.1038/Ng0695-151 |
0.373 |
|
| 1995 |
Peral B, Gamble V, Millán JL, Strong C, Sloane-Stanley J, Moreno F, Harris PC. Splicing mutations of the polycystic kidney disease 1 (PKD1) gene induced by intronic deletion Human Molecular Genetics. 4: 569-574. PMID 7633405 DOI: 10.1093/Hmg/4.4.569 |
0.494 |
|
| 1994 |
Ward C, Peral B, Hughes J, Thomas S, Gamble V, MacCarthy A, Sloane-Stanley J, Buckle P, Kearney P, Higgs D, Ratcliffe C, Harris P, Roelfsema J, Spruit L, Saris J, et al. The Polycystic Kidney-Disease-1 Gene Encodes A 14-Kb Transcript And Lies Within A Duplicated Region On Chromosome-16 Cell. 77: 881-894. PMID 8004675 DOI: 10.1016/0092-8674(94)90137-6 |
0.442 |
|
| 1994 |
Viribay M, Ferreira R, Peral B, Bello D, Ward CJ, Dávalos J, Valle C, Harris PC, Méndez del Castillo D, Moreno F. Genetic analysis of Cuban autosomal dominant polycystic kidney disease kindreds using RFLPs and microsatellite polymorphisms linked to the PKD1 locus. Human Genetics. 94: 432-6. PMID 7927343 DOI: 10.1007/Bf00201607 |
0.427 |
|
| 1994 |
Brook-Carter PT, Peral B, Ward CJ, Thompson P, Hughes J, Maheshwar MM, Nellist M, Gamble V, Harris PC, Sampson JR. Deletion of the TSC2 and PKD1 genes associated with severe infantile polycystic kidney disease--a contiguous gene syndrome. Nature Genetics. 8: 328-32. PMID 7894481 DOI: 10.1038/ng1294-328 |
0.427 |
|
| 1994 |
Harris PC, Thomas S, MacCarthy AB, Stallings RL, Breuning MH, Jenne DE, Fink TM, Buckle VJ, Ratcliffe PJ, Ward CJ. A large duplicated area in the polycystic kidney disease 1 (PKD1) region of chromosome 16 is prone to rearrangement. Genomics. 23: 321-30. PMID 7835880 DOI: 10.1006/Geno.1994.1507 |
0.394 |
|
| 1991 |
Harris PC, Thomas S, Ratcliffe PJ, Breuning MH, Coto E, Lopez-Larrea C. Rapid genetic analysis of families with polycystic kidney disease 1 by means of a microsatellite marker The Lancet. 338: 1484-1487. PMID 1683919 DOI: 10.1016/0140-6736(91)92300-Q |
0.394 |
|
| 1990 |
Harris PC, Barton NJ, Higgs DR, Reeders ST, Wilkie AOM. A long-range restriction map between the α-globin complex and a marker closely linked to the polycystic kidney disease 1 (PKD1) locus Genomics. 7: 195-206. PMID 2347584 DOI: 10.1016/0888-7543(90)90541-2 |
0.305 |
|
| 1990 |
Wilkie AOM, Lamb J, Harris PC, Finney RD, Higgs DR. A truncated human chromosome 16 associated with α thalassaemia is stabilized by addition of telomeric repeat (TTAGGG)n Nature. 346: 868-871. PMID 1975428 DOI: 10.1038/346868A0 |
0.31 |
|
| Show low-probability matches. |